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Summary
Immunohistochemistry is the application of antigen-antibody interactions plus a detection 
system to tissue sections for the purpose of identifying and localising a given substance.
Widely applied in the fields of research science and medical diagnostic pathology, 
immunohistochemistry is beginning to be used in diagnostic veterinary pathology and this 
work was performed to investigate the potential of the technique in assisting with certain 
histological challenges.
Chapter one provides a broad technical introduction to immunohistochemistry, 
highlighting the strengths and pitfalls of the technique, and concludes with a literature 
review which focuses particularly on the rapidly expanding veterinary literature dealing 
with the use of immunohistochemical methods.
Chapter two describes the use of specific antibodies to determine the cell of origin of 
thymic tumours in a variety of species. These commercially available antibodies were 
raised against human epitopes but were found to be effective on domestic animals. 
Immunohistochemistry was found to be invaluable in differentiating between thymic 
epithelial and lymphoid tumours.
In chapter three antibodies to specific subclasses of cytokeratin were applied to canine 
tissues and found to be effective at localising different cytokeratins in normal canine skin 
and in a range of epithelial tumours.
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In chapter four the identification of a nuclear tumour suppressor gene protein, p53, by 
immunohistochemistry is described. Immunohistochemical detection of this protein 
indicates abnormal functional status of p53 which occupies a pivotal role in the cell’s 
response to DNA damage. A panel of anti-human p53 antibodies were used on canine, 
equine and bovine tumours and very high levels of p53 protein expression were detected 
in equine squamous cell carcinomas.
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Chapter One 
Putting Immunohistochemistry in Context
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1.1.1) The Historical Perspective.
Microscopes have been used in the study of the minute anatomy of animals and plants for 
more than three hundred years. The term cell was first used in 1665 by Robert Hooke to 
describe the compartments he observed microscopically in a thin slice of cork. The term 
histology, from the Greek hist os (tissue) and logos (study), was coined in 1819 by a 
microscopist named A.F.J.K. Mayer but the concept of different tissues existing in the 
body was first propounded by Marie F.X. Bichat (1771-1802), a French anatomist who 
introduced the word tissue, from the French tissu for texture or weave, to biological 
science. Bichat did not use a microscope in his studies but made his observations from 
gross dissections. By 1839, Schwann in the field of zoology and Schleiden in the field of 
botany had independently published their conclusions that nucleated cells were the basic 
unit of life and the science of modem histology, where the body was recognised to be 
composed of cells and tissues, began to emerge.
Considering the body to be made up of a number of basic building blocks or tissues was 
very important for the development of the new science of histology as recurring 
microscopic arrangements were recognised in successive areas of the body as they were 
studied. In this way, the structure and function of the individual tissue types could be 
considered and the study of complex structures like organs logically approached and 
simplified. A tissue based approach also paved the way for an understanding of the 
embryological development of the body.
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Initially histologists examined membranes, scrapings and tissues pressed thinly using a 
device known as a compressorium, but untreated, living cells are unrewarding to examine 
microscopically as they are transparent and comparatively thick. Most cellular 
components have similar refractive indices and are difficult to identify in this way. 
Therefore, over the following half century this study of living (surviving) cells was 
superseded by the investigation of preserved dead cells as developments in fixation, 
processing and staining made this possible.
Although as early as 400BC the Greeks and Persians knew something of the action of 
mercuric salts and although the preservative effects of alcohol have been recognised for a 
long time it was the latter half of the nineteenth century which saw systematic 
investigations of fixatives undertaken. Numerous formulae were developed, many simply 
variations on common themes. Also around this time the production of synthetic dyes 
began. These investigations into the technical challenges of tissue processing were 
stimulated by the development of tissue sectioning and microscopic examination as 
carried out by the pioneers of histology.
At its beginning histology was a descriptive anatomical science but over time it has 
developed into a complex discipline where studies of the structure, composition and 
function of the tissues are linked. Modem histology is a wide science with specialised 
sub-divisions such as histochemistry, immunohistochemistry and autoradiography. It is, 
of course, also the basis of histopathology- the study of cell and tissue changes in disease.
22
1.1.2)Tissue Processing
Tissue processing refers to any treatment of tissues undertaken to facilitate the production 
of sections for microscopic examination. Processing may be considered to begin with 
tissue selection and appropriate trimming. The following is a brief outline of the 
principles and common methods of tissue processing.
Fixation
Fixation fulfils several purposes. It prevents autolysis and bacterial attack and hardens the 
tissue for subsequent sectioning. It stabilises structural components to preserve their in- 
vivo characteristics and can enhance staining by acting as a mordant. Importantly, fixation 
also protects those handling the tissues through its antiseptic properties. Stabilisation and 
hardening are due to crosslinking of proteins. The action of formaldehyde on proteins is 
reviewed by Pearse and Hopwood (1985). Reaction between formalin and proteins 
proceeds relatively slowly and is largely reversible by excess water whilst the reaction 
between proteins and glutaraldehyde is rapid and essentially irreversible. The chemistry 
of glutaraldehyde-protein interaction is considered by Hardy, Nicholls and Ryden (1976).
The ideal fixative is one which prevents tissue degradation whilst keeping the tissues as 
close to their living state as possible, renders the tissue suitable for and stable to further 
processing and does not allow alteration or loss of the constituent chemicals. In practical 
terms fixation methods are selected with reference to the types of investigation to be 
carried out on the tissue.
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In 1960 Baker introduced a classification system which described fixatives as coagulants 
or non coagulants and named protocols after the worker who introduced them, 
disregarding minor variations. Currently fixatives may be most conveniently classified 
according to their chemical nature (Table 1).
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Chemical Fixatives
Aldehydes formaldehyde
paraformaldehyde
glutaraldehyde
Oxidising Agents osmium tetroxide 
potassium dichromate
Protein Denaturing Agents acetic acid 
methyl alcohol 
ethyl alcohol
Undefined Mechanism mercuric Chloride 
picric Acid
Table 1. List of common fixatives grouped according to chemical action.
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In practice, by far the most commonly employed fixative is neutral buffered formalin 
prepared using 4% formaldehyde.
Dehydration
After fixation is complete the tissue blocks are dehydrated through a graded series of 
alcohols which remove aqueous and most lipid tissue constituents. This is necessary 
because the solidifying media are not, except in special circumstances, water miscible.
Clearing
After dehydration a clearing agent, a fluid miscible in both the dehydrating agent (usually 
alcohol) and the embedding media (usually paraffin wax) is used to remove the 
dehydrating agent from the tissues. Alcohol itself is not miscible with paraffin wax. 
Clearing agents ideally have rapid action and low capacity for tissue damage. 
Traditionally xylene, which can have carcinogenic effects, was the most commonly used 
clearing agent but now xylene substitutes of reduced toxicity are used.
Embedding
The process of embedding gives tissues physical support to allow sectioning for 
microscopy. Paraffin wax is a long established embedding medium and is still the most 
popular. It is convenient to handle, produces good staining results and is inexpensive. 
Alternative embedding media, including various resins, are available and are used to 
produce ultra-thin sections for electron microscopy or to support very hard tissues for 
sectioning.
Most laboratories use automated tissue processing for the bulk of their samples although 
very small pieces of tissue or urgently required samples may be processed by hand. The 
end result of either automated or manual processing is a tissue block from which sections 
may be taken.
Section Cutting
Sections are cut from paraffin embedded blocks using a microtome, floated out on a 
warm water bath and picked up on glass microscope slides. The sections are dried, 
usually in a 60°C oven, and are then ready to be dewaxed and stained.
Frozen Sections
In some situations, for example the handling of an urgent surgical biopsy, or for use with 
specialist techniques in CNS histology or enzyme histochemistry (after pre-fixing), frozen 
sections may be used in preference to conventionally processed ones. These sections are 
cut, usually unfixed, on a cryostat machine in which the tissue is cooled to a selected 
temperature for optimal sectioning. The sections may be briefly fixed, then stained, 
mounted and examined. This has the advantage of great speed but cryostat sections never 
possess the morphological clarity of conventionally processed sections as the tissue is 
unavoidably damaged by the freezing process (ice crystal artefact).
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1.1.3) Histological Staining
Staining of tissues is employed to introduce contrast between different cell and tissue 
components. The majority of histological stains were originally used as textile dyes and 
almost all dyes in current use are synthetic. Haematoxylin, which is extracted from the 
heartwood of the tree Haematoxylon campechianum is an important exception.
Stains may be actively taken up by living cells in “vital” or “supravital” staining, but 
more usually staining is determined by tissue affinity for the dyestuff. A detailed 
discussion of the physico-chemical interactions which co-operate to produce tissue 
staining is beyond the scope of this review but processes including van der Waals, ionic, 
hydrogen and covalent bonding all have roles to play. In some cases the underlying 
mechanism of the staining is poorly defined. Pearse (1980) and Thompson (1966) provide 
comprehensive overviews of histochemical theory whilst Bird and Boston (1975) and 
Vickerstaff (1954) provide a mass of technical information on dyes from their application 
in the textile industry.
Several aspects of the chemical behaviour of a given stain are important. The rate of 
uptake of a stain by different tissue constituents can be manipulated to produce 
differential staining in rate controlled staining protocols. For example, Alcian Blue 
rapidly stains mucins and can be used to identify these substances but if the stain 
incubation were sufficiently prolonged, other basophilic materials, such as cell nuclei 
would also stain. Similarly, the rate of loss of stain can be used as a means of
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differentiation. In this technique all tissue components are stained, with or without heat or 
a stain penetration enhancer like phenol, and then treated with a solvent which removes 
the stain at different rates from different structures. Luxol Fast Blue is used in this way to 
highlight myelin. Some dyes are particularly useful in their ability to stain different tissue 
components different colours. This property, known as metachromasia, allows mast cell 
granules, cartilage matrix and mucins to be highlighted by staining with Toluidine Blue 
or Methylene Blue which stain these substances reddish-purple against a blue 
background.
Obviously, to be demonstrated by a stain a tissue component must remain present in the 
section through fixation and processing. Hence the method of fixation will influence 
staining patterns according to the preservation of various substances. Fixatives may elute 
substances altogether or react with them producing derivatives which do not stain. Lipids, 
for example, are well preserved by fixation in osmium tetroxide but poorly retained in 
formalin. The reverse is true in respect of proteins.
The most useful staining procedure for routine histology and histopathology is the 
combination of haematoxylin and eosin. The haematoxylin stains the basophilic elements 
such as the cell nuclei and provides good nuclear detail. The dye produces a reddish 
colour which turns blue in mild alkali such as tap water in hard water areas or in Scot’s 
tap water substitute (distilled water plus magnesium sulphate and potassium bicarbonate). 
Initially the sections are overstained and some of the colour removed in acid-alcohol to 
produce greater differentiation. Eosin, a derivative of fluorescein, is a pink/red stain 
particularly effective for use in combination with haematoxylin. Of particular merit is its
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capacity to allow distinction between the cytoplasm of different cell types and between 
different connective tissue substances. This is due to differential loss of the stain through 
tap water washing and alcohol dehydration. The intensity of the stain may be adjusted 
according to the preference of the histologist or pathologist.
Histochemistry
Histochemistry is defined as that branch of histology which deals with the identification 
of chemical compounds in cells and tissues. Histochemical techniques are a refinement of 
routine histological staining.
In a diagnostic service histochemical methods are often referred to as “special stains” and 
are employed in the small proportion of cases where the haematoxylin and eosin section 
is not considered to provide sufficient diagnostic information. These stains are chosen 
with reference to the appearance of the standard section and are used to visualise a 
particular feature or answer a specific question about the tissue.
Routine histochemical stains can be used to visualise the five broad types of chemical 
substances found in mammalian cells. These substances, and commonly used stains for 
them, are listed in Table 2.
The scope and value of histochemical methods in diagnostic pathology is ably reviewed 
by Stoward (1990) whilst Culling (1974) provides a great deal of technical and practical 
information regarding histochemical staining.
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Substances Identifiable by Histochemical Methods
Substance Group/Residue Method
Nucleic acids phosphate methyl green /pyronin
deoxyribose Feulgen- Schiff
Proteins amine phloxine-tartrazine
thiol ferric ferricyanide
Mucosubstances vicinal glycol PAS
sialic acid Alcian Blue
specific saccharides lectins
Lipids long aliphatic chains Oil red 0  (all lipids)
free fatty acids Nile Blue Sulphate
Metals Iron Perl’s method
Calcium Von Kossa
Table 2. Outline of substances commonly localised by the use of histochemical stains. 
(Prepared with reference to Stoward 1990.)
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1.2.1) Immunohistochemistry: An introduction.
Immimohistochemistry, or immunocytochemistry as the technique is sometimes referred 
to, is the use of specific antigen-antibody interactions plus a detection system to identify 
cell or tissue constituents in situ.
The science of immunohistochemistry had its beginnings in 1941 when Albert H. Coons 
used a fluorescein labelled antibody directed against streptococcal antigens (Coons, 
Creech and Jones 1941). Later he also employed an indirect immunofluorescence method 
to trace plasma cells, again in relation to streptococcal antigen distribution. Coons’ work 
was oriented solely towards immune responses to microbial agents and it was some time 
before alternative uses for immunohistochemistry were developed.
As stated above, immunohistochemistry makes use of the specific nature of antibody- 
anti gen interaction to identify constituents of interest. Various methods exist to render the 
bound antibody detectable. If the antibody is to be labelled this must be accomplished 
without markedly compromising its ability to bind to its target antigen. Methods which 
employ several steps or layers avoid directly labelling the primary antibody and allow the 
visible end reaction to be amplified with respect to the primary antibody.
It is important to include adequate controls with immunohistochemical procedures. 
Tissue known to express the desired antigen should always be included to prevent 
technical problems producing false negatives; if the positive control fails to stain then the
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test batch must be rejected and the reagents and procedures checked to identify the 
problem. Negative controls of each test section where the primary antibody is replaced by 
pre-immune serum or irrelevant antibody must similarly be included to check for spurious 
staining due to non-specific binding of other reagents. The test sections are then 
compared with their corresponding negative control to identify background staining.
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1.2.2)Primary antibodies in immunohistochemistry
Primary antibodies used in immunohistochemistry may be either monoclonal (identical 
immunoglobulin molecules produced by a single clone of plasma cells) or polyclonal 
(derived from different cell clones). Licensed establishments may maintain animals for 
polyclonal sera or ascites production, but many commercial sources of antibody exist.
Polyclonal immune serum, produced by repeated immunisation of the animal with the 
required antigen, contains around lOmg/ml immunoglobulin, 1-10% of which will be the 
antibody of interest. The serum must be purified to remove unwanted proteins and other 
materials. Immunoglobulins may be precipitated using ammonium sulphate as an initial 
step (England and Seifter, 1990). The crude immunoglobulins isolated by this method can 
be purified by affinity chromatography where the antibody of interest is specifically 
bound and subsequently recovered. This technique is comprehensively reviewed by 
Ostrove (1990). Ascites fluid contains l-10mg/ml immunoglobulin, approximately 90% 
of which will be the desired antibody and this is similarly purified before use.
The production of monoclonal antibodies requires tissue culture facilities for spleen 
fusion and hybridoma selection. Once established these cells provide an almost limitless 
supply of the specific antibody (Kohler and Milstein 1975, Galfre and Milstein 1981). 
Hybridoma culture supernatants yield 0.05-lmg/ml of immunoglobulins and the specific 
antibody is removed by affinity chromatography or by concentration using ammonium 
sulphate fractionation and dialysis.
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Several characteristics are required of an antibody for it to be diagnostically useful. In 
particular the antibody should be of high specificity and sensitivity. These characteristics 
may be defined as follows:
specificity = true negatives______ % sensitivity =  true positives %
true negatives+false positives true positives+false negatives
In practice it is difficult to produce an antibody of both high specificity and sensitivity. 
Most markers with high specificity, e.g. >90%, are of lower sensitivity e.g. <70% and 
vice versa. However, carefully chosen antibodies or panels of antibodies can produce a 
good combination of sensitivity and specificity.
Versatility, which relates to the ability of the antibody to work successfully on a range of 
substrates, is another desirable quality for an antibody. Frozen sections, unfixed 
preparations and formalin or otherwise fixed, paraffin embedded sections are all targets 
for immunohistochemical investigation. In practice it has been found that antibodies 
known to work well on formalin fixed, paraffin embedded tissues tend to be effective on 
a wide range of preparations. These antibodies are also the most suitable for use in 
routine diagnostic procedures as formalin fixed, paraffin embedded material is convenient 
to work with and store (see 1.1.2).
Remaining considerations in antibody selection include cost, availability and shelf-life. 
The use of commercially prepared antibodies has some advantages in terms of external 
quality control. Although an enormous range of antibodies are available almost all of 
these are designed for use on human tissue (a range are also designed for mouse).
Researchers using these antibodies in other species must be especially careful to employ 
adequate controls to validate their results.
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1.2.3) Immunofluorescence
i)Direct Immunofluorescence
This technique, originally developed by Coons in 1941, involves labelling the primary 
antibody with a fluorochrome (see later). Labelling the antibody directly with dye has 
proven to be ineffective as the result is not sufficiently visible under the microscope. The 
major disadvantage of this system is its lack of versatility, each individual primary 
antibody requires to be bound to a suitable fluorochrome, a time consuming and 
expensive process. Also the signal intensity tends to be poor as only one fluorescently 
labelled antibody molecule is bound to each antigenic site.
ii)Indirect Immunofluorescence
This technique, a progression from direct immunofluorescence, was developed in the 
1950s (Coons, Leduc and Connolly 1955, Holborrow, Weir and Johnson 1957). In the 
first step unlabelled primary antibody is applied to the section. This is followed by a 
heterologous fluorochrome labelled anti-immunoglobulin secondary antibody. As the 
secondary antibody can be used against any primary antibody of the same species (usually 
mouse for monoclonals) and class (almost invariably IgG) this technique allows far 
greater flexibility and economy. It also offers increased sensitivity as it avoids processing 
of the primary antibody during labelling with its inevitable effect on activity and,
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importantly, more than one labelled secondary antibody can bind to each primary 
antibody and amplify the fluorochrome signal.
Both immunofluorescence techniques have certain inherent drawbacks which make them 
unsuitable for routine use. For example, these techniques are not suitable for use on 
formalin fixed paraffin embedded material - the substrate of choice for routine 
investigations - due to the autofluorescence associated with these preparations. Also, 
counterstaining to reveal tissue morphology is not possible with fluorescent labelling. 
Another problematic feature is the impermanency of fluorescent preparations which fade 
and cannot be routinely mounted.
Fluorochromes
Of the many known fluorochromes only a small number are used in immunofluorescence 
studies. The most common is fluorescein, a green emitter with maximum fluorescence in 
light of 400-520 pm wavelength, which has been in use since the pioneering studies of 
Albert Coons. Fluorochromes are usually conjugated to antibodies via reactive 
isothiocyanate groups. Red emitting fluorochromes such as rhodamine and its derivatives 
are also quite widely used (Titus et al. 1982). More recently, phycobilliproteins, intense 
natural fluorochromes extracted from algae, have found applications in biological 
science. One major group of phycobilliproteins, the phycoerythrins, have been used 
successfully in immunofluorescence despite their large size (up to 2410kDa mw) which 
can give rise to steric hindrance of binding (Pizzolo and Chilosi 1984).
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It is possible to double or multiple label sections to allow localisation of more than one 
antigen in the same tissue providing the fluorescent signals can be differentiated. Texas 
Red, a rhodamine derivative is suitable for combination with fluorescein for this purpose 
as their emission spectra have minimal overlap. In this technique primary antibodies 
which differ from each other in terms of species of origin or immunoglobulin class are 
applied followed by differently labelled corresponding secondary antibodies.
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1.2.4) Immunoenzyme Detection Systems
Indirect immunoperoxidase method
Originally developed by Nakane and Pierce in 1966 and refined by Avrameas (1969) and 
Nakane and Kawaoi (1974), this enzyme labelled secondary antibody system helped to 
overcome the problems associated with the indirect immunofluorescence method. It is a 
two step method in which application of an unlabelled primary antibody is followed by a 
horseradish peroxidase-linked secondary antibody conjugate directed at the primary 
antibody species and immunoglobulin class.
This method has the advantages of simplicity, speed and wide commercial availability of 
reagents and it avoids problems associated with antibody bridge formation (see later). It 
may be applied to conventionally processed sections. Drawbacks of this technique are 
lack of efficiency in comparison with multi-step protocols due to lower intrinsic signal 
amplification, reduction in enzyme (and antibody) activity caused by their chemical 
coupling and potential background staining due to non-specific binding of the secondary 
antibody to endogenous immunoglobulins present in the tissue under examination. The 
last is a problem common to all methods using anti-immunoglobulin secondary 
antibodies.
Peroxidase-antiperoxidase (PAP) method
This technique was developed as an advance from the earlier indirect immunoperoxidase 
techniques (Stemberger et al. 1970). It allows the delivery of a greater number of enzyme
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molecules to each antigenic site. The PAP method is a three step antibody bridge system. 
Unlabelled primary antibody is first applied, followed by a bridging antibody specific to 
the primary antibody species and immunoglobulin class. The bridging antibody will 
usually be IgG and must be added in excess to ensure that it binds to the primary antibody 
with only one of its two antigen binding sites. The free binding site must be available to 
react with a preformed peroxidase-antiperoxidase complex which is added in the third 
step. This reagent includes an antibody raised against the enzyme horseradish peroxidase 
(HRP) which is of the same species and class as the primary antibody. The bridging 
antibody therefore links the primary antibody and the PAP complex.
This technique offers very high specificity as the two binding sites of the bridge antibody 
are identical and produce a precise immunohistochemical correspondence between the 
primary antibody and the PAP complex. It is also efficient in terms of signal 
amplification with the primary antibody capable of binding several bridging antibodies 
and the PAP complex capable of delivering three HRP molecules to each bridging 
antibody.
However, this technique has several disadvantages. It lacks versatility, requiring PAP 
complexes specifically designed for each different species and immunoglobulin class of 
primary antibodies plus specific bridging antibodies. This naturally increases the expense 
of the technique. As with some of the other techniques interference from endogenous 
immunoglobulins can result in high background staining, especially on frozen sections. If 
the bridge antibody is not sufficiently in excess of the primary antibody it will tend to 
bind to it with both of its available binding sites leaving none available to interact with
the PAP reagent. Hence at supraoptimal primary antibody concentrations the intensity of 
the final staining is actually reduced. This apparently paradoxical finding, known as the 
Bigbee effect, is named after the researcher who determined the explanation for it 
(Bigbee, Kosek and Eng 1977).
Alkaline phosphatase-antialkaline phosphatase method (APAAP)
This method follows the same principles as the above PAP method except that the 
enzyme against which an antibody is raised is alkaline phosphatase (Cordell et al. 1984). 
This is less commonly used than the previous technique as background staining is often 
more problematic. APAAP is used in selected circumstances such as bone marrow 
staining where the tissue in question has endogenous peroxidase activity that is difficult 
to quench effectively (see 1.2.5).
Avidin-Biotin Methods
Another approach to multistep immunohistochemical labelling utilises the very high 
affinity between avidin, a 68kDa mw. glycoprotein found in egg white and biotin, a 
member of the vitamin B complex. These two molecules bind together almost 
irreversibly. Covalently coupling biotin to a protein (e.g. an immunoglobulin) gives that 
protein the ability to bind avidin which in turn may be covalently joined to ligands such 
as enzymes, fluorochromes or other proteins. Each avidin molecule can bind four biotins 
and each biotin molecule has two binding sites for avidin (Bratthauer 1994).
There are two main techniques in use in immunohistochemistry which are built around 
the avidin-biotin system:
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i) Covalent conjugate or labelled avidin (LAB) method
In this method a primary or more usually secondary biotinylated antibody is followed by 
the addition of a covalent conjugate between avidin and an enzyme, fluorochrome or 
other marker. The “avidin” used in this method is usually streptavidin, a molecule 
obtained from the bacterium Streptomyces avidinii which has similar excellent biotin 
binding properties and a reduced tendency toward non-specific binding. This technique is 
used widely in immunohistochemistry and immunofluorescence (Elias, Margiotta and 
Gabore 1989, Milde et al. 1989).
ii) Avidin-biotin complex (ABC) method
In the ABC technique the application of a biotinylated primary, or again more commonly 
secondary, antibody is followed by the addition of a preformed complex of avidin and 
biotinylated enzyme which forms a lattice and stays in solution. The ratio of avidin to 
biotin in the complex is such that a binding site for the biotinylated secondary antibody is 
available (Hsu, Raine and Fanger 1981). This method is illustrated in Figure 1.
The advantages of the ABC and LAB techniques for immunohistochemistry include the 
reliable nature of the affinity between avidin and biotin which is not as demanding in 
terms of conditions for success as are some wholly immunological interactions. These 
two methods are also extremely sensitive due to their capacity to deposit many enzyme 
molecules at each antigenic site. This sensitivity allows high dilution of the primary 
antibody which is desirable in terms of reduced cost and also reduces background staining 
due to non-specific primary antibody binding. The reagents themselves are more
43
universal in application as biotinylated secondary antibodies are easily produced and 
widely available which gives these techniques further advantage over the inflexible PAP 
method in terms of economy.
In terms of disadvantages, steric hindrance due to the large size of the ABC complex can 
reduce binding capacity in some circumstances and some tissues, especially fresh or 
frozen tissues, have endogenous biotin or biotin-like activity and are difficult to examine 
by these methods.
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AVIDIN-BIOTIN PEROXIDASE METHOD
B
C h r o i n o g e n
biotinylated secondary antibody
primary antibody 
I tissue section
Figure 1. Schematic representation o f  the multiple steps in the ABC method. 
A = avidin 
B = biotin 
P =  peroxidase
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1.2.5) Enzymes and Chromogens
The visible signal in immunoenzyme techniques is generated when the enzyme, acting on 
a substrate, catalyses a reaction in a chromogen which results in a detectable colour 
change. To be of use in immunohistochemistry the reaction must produce an insoluble 
precipitate.
The most commonly used enzyme in immunohistochemistry is peroxidase, which has an 
oxidative function in the presence of a source of oxygen (hydrogen peroxide, H2O2). 
Horseradish peroxidase (HRP) is most commonly used as it is easily obtained and has 
antigenic differences from most mammalian forms of the enzyme. For use in conjunction 
with this enzyme, a chromogen which changes colour and produces an insoluble pigment 
when oxidised is required. Many tissues have endogenous peroxidase activity with the 
potential to cause heavy background staining, but fortunately this activity is effectively 
quenched by pre-incubating the tissue sections in a hydrogen peroxide/methanol or 
hydrogen peroxide/ water solution (Streefkirk 1972, Bums, Hambridge and Taylor 1974). 
An exception to this is the myeloperoxidase activity in bone marrow for which alternative 
enzyme systems are preferred.
The most widely used chromogen in peroxidase systems is probably 3,3- 
diaminobenzidine (DAB) which produces a brown precipitate. It is favoured because it is 
effective in quickly adhering to the tissue at the site of its generation and its polymer is 
resistant to the dehydrating and clearing agents (alcohols and xylenes) allowing
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conventional mounting of the slides. The colour produced is stable in long term storage. 
A possible disadvantage to using DAB is the similarity of its colour to some endogenous 
pigments such as melanin, haemosiderin and lipofuschin. It is, however, possible to 
modify the coloured end-product by carrying out the reaction in the presence of heavy 
metal ions. The presence of nickel, for example, produces a dense black pigment ideal for 
multiple staining or highlighting a very faint colour reaction (Shu, Ju and Fan 1988).
An alternative chromogen to DAB is 3-amino-9-ethylcarbazole (AEC) which produces a 
red deposit. This can produce better contrast than DAB in some circumstances. The major 
drawback to the use of AEC is that it is soluble in the dehydrating and mounting agents 
used routinely and aqueous mounting is required.
Another enzyme used in immunohistochemistry is alkaline phosphatase. This enzyme 
cleaves phosphates off a donor molecule which in turn acts as a mediator of colour 
change in a third molecule. This system produces more coloured molecules per enzyme 
molecule than peroxidase and is hence potentially more sensitive. Alkaline phosphatase 
may be preferred for examining protein or nucleic acid blots or tissue cultures but is less 
commonly applied to routine tissue sections as alkaline phosphatase activity is 
widespread in tissues. Pre-treatment with levamisole to block this activity is possible but 
is not as dependable as quenching peroxidase with hydrogen peroxide (Ayala et al. 1993).
A variety of chromogenic substrates are available for use with alkaline phosphatase. A 
combination of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and nitro blue tetrazolium 
(NBT) produces a permanent blue precipitate at the site of the enzyme localisation whilst
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Fast Red TR/Napthol AS-MX (Sigma, Poole, Dorset, England) produces a red 
precipitate.
Glucose oxidase is occasionally used as the enzyme system of choice (Jasani 1992), 
largely in cases where background enzymatic activity is a problem, as glucose oxidase 
activity is not found in mammalian tissues.
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1.2.6) Antigen retrieval
A vast array of antigens can be localised using immunohistochemistry but in many cases 
special treatment of the tissue sections is necessary to render the antigens available for 
binding with their specific antibody. The basic purpose of these treatments is to overcome 
the effects of fixation, hence they are not necessary on fresh preparations or frozen 
sections. As stated previously, however, formalin fixed paraffin embedded sections are in 
many respects the “gold standard” of histological preparations and a great deal of interest 
has been focused on how to maximise the use of immunohistochemistry, which was 
originally applied to frozen sections, in these preparations.
Formalin fixation causes cross-linking between reactive sites on the same or adjacent 
proteins which alters the antigenicity of the tissue, although it appears that it does not 
alter the secondary structure of proteins (Mason and O’Leary 1991). A minority of 
antigens, particularly cell surface markers, are destroyed by fixation per se but studies 
using special processing techniques have produced tissues with reactivity comparable to 
frozen specimens when reacted with antibodies against antigens which do not resist 
routine processing (Codings, Poulter and Janossy 1984). This finding suggested that 
fixation need not destroy antigens and stimulated further interest in the possibilities of 
recovering the antigenicity of routinely processed tissues. It has been found that for the 
majority of antigens, which are not irretrievably destroyed by conventional processing,
50
fairly simple treatment can unmask those which would be otherwise unavailable and 
enhance the reactivity of others which partially withstand fixation.
There are two basic types of antigen retrieval: enzymatic and heat-mediated. Enzymatic 
antigen retrieval involves the application of a solution of trypsin (usually 0.05% trypsin, 
0.1% CaCl2 in phosphate buffered saline {PBS}) or a similar proteolytic enzyme, such as 
the commercially available Pronase E (Sigma, Poole, Dorset, England), to break down the 
protein linkages induced by fixation. Protocols are adjusted with different incubation 
times and temperatures as required. There are two main methods of heat-mediated antigen 
retrieval; microwave oven and pressure cooker processing. In both of these methods the 
tissue sections are immersed in a buffered solution (usually a citrate solution) which is 
allowed to boil (Cattoretti et al. 1993, Shi, Key and Kalra 1991). Again the action of these 
treatments aims to break down the bonds formed during processing and re-expose the 
desired antigenic sites. The pitfalls of antigen retrieval techniques are twofold. Firstly 
both enzymatic and heat treatment is damaging to the tissues. This leads to poorer 
preservation of morphology or, at worst, destruction and loss of tissue sections. The other 
potential problem is alteration of antigenicity in the tissue where the pre-treatment itself 
generates spurious positive reactions.
It is therefore necessary to determine the least damaging protocol effective for a particular 
tissue and antigen and to apply meticulous controls to guard against unrecognised false 
positives.
51
1.3.1) Applications of immunohistochemistry
The applications of immunohistochemistry in research and basic science are numerous. 
This technique has been widely used wherever localisation of specific substances is of 
value. Antibodies may be raised against specific gene products, surface markers, 
microbial antigens, subcellular constituents, in fact almost any antigenic determinant 
according to requirements, making the technique extremely versatile.
Particular veterinary research fields in which immunohistochemistry is extensively 
utilised include endocrinology, where the technique has been applied, for example, to 
studies of the neuroendocrine system of the lungs (Rodrigez et al. 1992, Lopez et al. 
1993), gastrointestinal endocrine function (Ceccarelli, Pedini and Gargiulo 1995, 
Martinez, Lopea and Sesma 1993, Calingasan et al. 1984) and pancreatic endocrine 
function (Taniyama et al. 1993, Furuoka et al. 1989, Atkins et al. 1988, Nakajima et al. 
1988).
In the field of neuroanatomy/neurophysiology Bowker et al. (1993) used 
immunohistochemistry to identify sensory receptors in the equine foot, Hewicker 
Trautwein et al. (1994) to localise glial and neuronal cell markers in the developing 
bovine brain and Prieto et al. (1993) to examine the innervation of the equine ureter.
Parasitology is another discipline where the literature on work involving 
immunohistochemistry is very extensive. This technique allows, for example, localisation
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within the parasite of antigens which provoke a serological response in the host. Specific 
antigens have been localised in nematodes such as Trichinella spiralis (Takahashi et al. 
1988, Li and Bao 1994) and Ancylostoma caninum (Sawsngjaroen, Opdebeeck and Prociv 
1995), in protozoa including Plasmodium yoelii (Torii et al. 1992) and Entamoeba 
histiolytica (Sherchand et al. 1994), trematodes such as Fasciola spp. of liver fluke 
(Yamasaki, Kominami and Aoki 1992) and arthropod parasites including the louse 
Polyplax spinulosa (Volf 1994) and the ixodid tick Dermacentor variabilis (Davis, 
Dotson and Oliver 1994).
This review will focus on the diagnostic and related uses of immunohistochemistry and 
specifically highlight those areas in the field of veterinary pathology where the use of 
immunohistochemistry has been reported.
Immunohistochemistry in Diagnostic Pathology
As mentioned previously in this chapter, immunohistochemical techniques have been in 
use since the 1940s, at first as a specialised research tool for which frozen sections were 
required. When, in 1974, Taylor and Bums reported the immunohistochemical detection 
of plasma cell immunoglobulin in paraffin embedded tissues it was realised that 
immunohistochemistry could be developed into a powerful tool for use in diagnostic 
pathology. Quickly this work was repeated in other laboratories (Garvin et al. 1974, 
Davey et al. 1978) and the applicability of this technique to routinely processed tissues 
was confirmed. As mentioned previously (1.2.6) special fixation and processing protocols
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can extend the usefulness of some antibodies into paraffin embedded tissues but the range 
of commercially produced antibodies specifically designed for use in formalin fixed, 
paraffin embedded tissues, with or without antigen retrieval techniques is also increasing. 
These include antibodies to intermediate filaments, many leucocyte markers and tumour- 
associated proteins.
The examination of fixed, paraffin embedded tissues is of central importance to 
diagnostic histopathology. Techniques which allow the exquisitely specific and sensitive 
antibody-antigen interactions of immunohistochemistry to be combined with 
morphological interpretation of such samples probably represent the most important 
advance in the science of diagnostic pathology in recent years.
Another great advantage, aside from suitability for inclusion in routine diagnostic 
procedures, of staining paraffin embedded sections is that it allows retrospective, archival 
studies to be undertaken, making available a vast resource of material. 
Immunohistochemistry has been successfully performed on tissues stored since the last 
century and in at least one instance on tissues held in ethanol for thirty years (Celio 1979).
Tumour Diagnosis
Immunohistochemistry is of particular benefit to the diagnostic pathologist in certain 
situations. Perhaps the most important among these is the use of this technique in the 
diagnosis of tumours of unknown origin in cases where the morphology is not helpful or 
is poorly preserved. In such cases, where haematoxylin and eosin sections, together with 
more specific histochemical stains such as sirius red, PAS, PTAH or reticulin stains, fail
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to sufficiently identify the cells a panel of carefully chosen antibodies will be applied. The 
choice of this panel is tailored according to the pathologist’s judgement of the 
requirements of the particular case. It is impractical to use immunohistochemistry as a 
“fishing exercise” in the diagnostic situation as using a vast panel of antibodies would be 
prohibitively expensive and inefficient.
To determine the nature of a poorly differentiated tumour antibodies against cell lineage 
markers are used. The expression of these markers in a cell provides information on the 
neoplasm’s embryological derivation. The use of these markers in tumour diagnosis relies 
on the fact that most tumours retain similar markers of lineage to their tissue of origin 
(Cooper, Schermer & Sun 1985). Lineage markers include intermediate filaments, 
cytoskeletal components so named because they are intermediate in size between small 
filaments (e.g. actin) and large filaments (e.g. microtubules), the S-100 protein, 
carcinoembrionic antigen (CEA), Factor VIII related antigen (FVIII-RAG) and many 
lymphoid subset markers divided into CD (cluster of differentiation) groups. The major 
classes of intermediate filament are cytokeratins, vimentin, desmin, neurofilaments and 
glial fibrillary acid proteins (GFAP). Lineage markers will be discussed in greater detail 
in chapter two.
Interpretation of the immunohistochemical results must be made in the light of the 
morphological appearance of the tumour as in some cases malignant transformation can 
alter the expression of intermediate filaments causing unexpected expression, co­
expression or loss of expression (Corwin and Gown 1989).
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Another problem which immunohistochemistry is well suited to help solve is the 
detection and identification of small numbers of cells, for example, tumour cells in 
smears or aspirates (Ghosh, Mason and Spriggs 1983, Ghosh et al. 1985) or 
micrometastases in lymph nodes (Wells et al. 1984). These studies have shown that 
immunohistochemical techniques can yield positive results when classical morphological 
or cytological examination has been negative or equivocal. This is obviously 
advantageous in terms of determining prognosis and appropriate treatment.
Veterinary Tumour Pathology
As in human medicine, one of the veterinary fields in which immunohistochemistry has 
been employed is tumour investigation. The immunophenotyping of lymphoid neoplasia 
is an expanding area of interest. Caniatti et al. (1996) examined fine needle aspirates of 
tumourous canine lymph nodes, combining morphological examination with 
immunocytochemical analysis of cytospin preparations which allowed 
immunophenotyping and classification of the neoplastic cells. In 1994 Tanimoto et al. 
reported applying anti-IgG, anti-PCNA, anti-EBV and anti S-100 antibodies to formalin 
fixed, paraffin embedded sections from cases of alimentary lymphosarcoma (lymphoma) 
in swine. Their findings included monoclonal immunoglobulin expression which was not 
associated with albumin positivity. This allowed reliable identification of these cases as B 
cell lymphosarcomas (lymphomas) which can be difficult to distinguish from lymphoid 
hyperplasia (pseudolymphoma) (Fenoglio-Prieser, Pascal and Perzin 1990).
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Investigations on lymphoid cell populations in cases of Enzootic Bovine Leucosis (EBL) 
have demonstrated that EBL-associated tumours are neoplasms of mature B cells (Heeney 
and Valli 1990, Aida, Okada and Amanuma 1993). Recently, Chiba et al. (1995) used a 
panel of monoclonal antibodies against leucocyte differentiation molecules on lymph 
nodes and tumours from cases of EBL, divided the the lymph node lesions into three 
discernible patterns and classified the cells in the tumour masses.
Lymphosarcoma is the commonest haematopoetic neoplasm in the cat and the association 
of this disease with Feline Leukaemkia Virus (FeLV) is well documented (Hardy et al. 
1981). However, tumourigenesis including the development of lymphosarcoma, has also 
been reported in association with Feline Immunodeficicency Virus (FIV) infection 
(Hopper et al. 1989, Alexander et al. 1989, Shelton et al. 1990). In 1996 Callanan et al. 
described the histopathologic and immunohistologic examination of eight cases of 
lymphosarcoma in domestic cats with FIV. Seven were found to be high grade B cell 
lymphomas of the centroblastic or immunoblastic subtypes (modified Kiel classification). 
Burraco et al. (1992) similarly reported the use of immunohistochemistry to define the 
cellular lineage of a large granular lymphoma in a FIV positive/ FeLV negative cat.
Canine plasmacytomas have been studied with antibodies against immunoglobulin (Ig) 
light chains. The results have confirmed their plasma cell origins by demonstating the 
presence of these immunoglobulin molecules in the cells and have proven the neoplastic 
nature of these lesions by showing the cells are monoclonal (Brunnert and Altman 1991, 
Kyriazidou, Brown and Lucke 1989).
57
Sandusky, Carlton and Wightman (1987) reported a series of sixty-five canine “round 
cell” skin neoplasms which they studied using the avidin-biotin-complex (ABC) method 
on conventionally processed tissues. Mast cells were found to react with avidin and were 
consequently stained positively even on negative control sections. The authors considered 
S-100 (amelanotic melanoma), vimentin (amelanotic melanoma and transmissible 
venereal tumour) and Ig light chain (cutaneous lymphoma) to be the most useful 
antibodies to aid differential diagnosis of these neoplasms.
A case of disseminated malignant histiocytosis in a Golden Retriever was reported by 
Hayden et al. (1993). The authors used histology, electron microscopy and 
immunohistochemistry to diagnose this case. The neoplastic cells reacted positively with 
antibodies to human T-cell antigen, alpha-1-antitrypsin, cathespin B and lysosyme.
Pace et al. (1994) reported the immunohistochemical examination of a series of seven 
cases diagnosed as feline malignant fibrous histiocytomas. Archival biopsy specimens 
were stained for cytokeratins, vimentin, desmin, S-100 and alpha-1-antitrypsin. Four 
tumours stained with all antibodies except alpha-1-antitrypsin, one for vimentin only, one 
for S-100 and vimentin and one was uniformly negative. The authors conclude that feline 
malignant fibrous histiocytomas show diverse intermediate filament expression as does 
the human counterpart of this tumour and that they do not appear to be histiocytic in 
origin. They also suggest the three discordant biopsies in the series should be reclassified.
Immunohistochemistry has also been used in the investigation of endocrine neoplasms . 
Heinrichs, Baumgartner and Capen (1990) demonstrated a uniform pattern of primarily
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pro-opiomelanocortin (POMC) immunoreactivity in nineteen adenomas of the pars 
intermedia in horses with moderately strong melanocyte-stimulating hormone (MSH) 
immunoreactivity and weaker, more variable adrenocorticotrophic hormone (ACTH) 
positivity. This supports the concept of equine pituitary adenomas producing a unique 
clinicopathologic syndrome associated with excess production of POMC derived peptides 
with secondary involvement of ACTH, a different aetiopathogenesis from Cushing’s 
Syndrome in the dog. Endocrine disease of the canine pancreas has also been a target for 
immunohistochemical investigation. In 1987 Hawkins et al. used the technique to 
examine normal and neoplastic islets in formalin fixed, paraffin embedded sections of 
canine pancreas. Sub-islet localisation of glucagon, insulin and somatostatin producing 
cells was established. No gastrin staining was detected in the normal islets. Of twenty 
tumours, eight had immunoreactivity for insulin, nine for glucagon, fourteen for 
somatostatin and one for gastrin. Three were pure insulinomas but all the others had 
mixed hormone production.
The immunohistochemistry of equine pulmonary granular cell tumours has been 
investigated by various workers. In the series reported by Kelley et al. (1995) the 
cytoplasmic granules in the tumour cells were stained uniformly positive with S-100 and 
NSE. Bouchard et al. (1995) described three cases where the tumours were positively 
stained with S-100 and vimentin but negative for NSE. Both authors concluded that these 
neoplasms are of neural crest (probably Schwann cell) origin similar to the granular cell 
tumours recognised in humans (Miettinen et al. 1984).
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Vaan Maanen et al. (1996) reported the immunohistochemical examination of three cases 
of carcinoid tumour in the horse. All three were reactive for NSE and synaptophysin, 
confirming the neuroendocrine nature of these tumours.
Bovine pulmonary blastomas have also been examined using this technique and multiple 
pathways of differentiation within the tumour masses were demonstrated by Kelley et al. 
(1994) who used anti-vimentin, anti-actin, anti-cytokeratin and anti-NSE antibodies and 
found a mixed pattern of immunoreactivity in the neoplastic cells.
Tumours of neural tissue have also been investigated immunohistochemically. Ribas et 
al. (1989) examined a series of canine choroid plexus tumours with lineage directed 
markers and found evidence of epithelial but not glial differentiation. 
Immunohistochemical studies of unusual neural neoplasms have aided their identification 
and demonstrated their origins. Carrigan et al. (1996) described an equine papillary 
ependymoma which was positive for GFAP and weakly positive for vimentin, whilst 
Mattix et al. (1994) reported a ganglioneuroblastoma in a dog with mixed 
immunoreactivity similar to such tumours in humans and other animals.
Vascular tumours, particularly accessible cutaneous ones, have been examined by 
immunohistochemical techniques. Miller, Ramos and Kreeger (1992) reacted 
haemangiomas and haemangiosarcomas in domestic cats with antibodies to Factor VIII- 
related antigen confirming the vascular endothelial origin of these growths. Similarly, 
Johnson et al. (1996) used this method to demonstrate the orderly arrangement between
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vascular endothelium and smooth muscle supporting cells in benign vascular neoplasms 
in young horses.
61
Immunohistochemistry in non-neoplastic disease
i)Viral Infections
Characterisation of neoplastic cells is not the only veterinary application of 
immunohistochemistry. An enormous literature exists dealing with the applications of 
this technique in investigating viral disease.
Haines, Clark and Dubovi (1992) screened thirty two monoclonal antibodies (mabs) to 
epitopes in the Bovine Viral Diarrhoea Virus (BVDV) and found only one (mab 15C5) 
which recognised an epitope preserved on formalin fixed, paraffin embedded tissues. This 
antibody was found to be effective and specific for immunohistochemical detection of 
BVDV in routine specimens. The same monoclonal antibody (15C5) was used by Bazler 
et al. in 1995 in a retrospective study of fifty cases of BVDV diagnosed by viral isolation. 
In the thirty-nine bovine animals in the study there was 100% concordance between 
immunohistochemistry and viral isolation. When testing was restricted to the intestinal 
tissue and/or faecal samples virus isolation detected BVDV in 65% of cases compared 
with immunohistochemistry which detected BVDV antigen in 100%. 
Immunohistochemical detection was poor in ovine and caprine cases where the virus had 
been isolated. Immunohistochemistry has also been used to determine antigen distribution 
in body tissues of specific pathogen free (SPF) calves experimentally infected with 
different strains of non-cytopathic BVDV (Marshall, Moxley and Kelling 1990). Once 
again mab 15C5 was used in this study which found different strains to have the same 
tissue trophism for thymus, Peyer’s patches, mesenteric lymph nodes and bone marrow.
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Central nervous system (CNS) lesions associated with persistent BVDV infection, 
Mucosal Disease and congenital malformations (attributed to in-utero infection with the 
virus) have been investigated immunohistochemically. In persistently infected animals 
and Mucosal Disease cases a widespread infection of neurons by the BVD virus was 
detected. In contrast, few cases with congenital CNS malformations showed viral antigen 
in the CNS, reflecting a competent immune response within the foetus at the time of 
infection (Wohrmann et al. 1992).
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) has been another target 
for immunohistochemical study in both natural and experimental infections. In 1996 
Halbur et al. used the technique to compare antigen distribution of different American 
PRRSV isolates and European Lelystad Virus in experimentally infected pigs. A similar 
pattern of virus antigen distribution in alveolar and other macrophages, lymph nodes, 
tonsils and spleen was found.
The involvement of PRRSV in four pig herds with abortions was confirmed using, 
serology, virus isolation and immunohistochemistry It was found that 
immunohistochemistry could demonstrate viral antigen in tissues where virus isolation 
was negative (Rossow et al. 1996). The same technique was used by Larochelle, 
Sauvageau and Magar (1994) to demonstrate PRRSV in lung sections from field cases of 
porcine proliferative and necrotizing pneumonia.
Immunohistochemistry has been used to investigate many morbillivirus infections 
including canine distemper, rinderpest and the closely related peste de petit ruminants
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(PPR). In 1991 Brown, Mariner and Olander successfully used anti rinderpest antibodies 
to localise PPR virus in conventionally processed respiratory tissues from experimentally 
infected goats. Brown and Torres (1994) used a similar technique to study the distribution 
of rinderpest virus in experimentally infected heifers. In these animals viral antigen was 
detected in lymphoid tissue and intestinal and respiratory epithelium.
Iwatsuki et al. (1995) examined lymphoid organs from dogs with natural Canine 
Distemper Virus (CDV) infections using anti-measles antibodies and a range of lymphoid 
cell markers. Histological examination showed lymphoid atrophy. The authors found that 
Thy-1 positive and CD4 positive T-cells were major targets for the virus during acute 
infection.
A survey of brain tissue from 236 wild carnivores (146 mustelids and 90 foxes) in 
southwestern Germany was reported by Van Moll et al. (1995). CDV antigen was 
detected by immunohistochemistry in 54 (37%) mustelids and in no foxes. Associated 
histopathological changes were found in 45% of the positive CDV cases. These results 
suggested a local CDV epizootic in the mustelid population.
In 1993, Alldinger, Baumgartner and Orwell conducted a detailed study of viral surface 
protein expression in canine distemper encephalopathies. The brains of sixteen dogs with 
natural infections were studied with antibodies against five major viral epitopes. The 
results indicated restricted CDV envelope protein synthesis in acute and more prominent 
synthesis in chronic distemper encephalitis.
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ii)BacteriaI Infections
Immunohistochemistry is also used in the investigation of non-viral infectious diseases. 
Recently (1996), Madrame et al. used immunohistochemistry to detect virulence- 
associated antigens of Rhodococcus equi in formalin fixed, paraffin embedded tissue 
from lungs of six clinically affected foals using a monoclonal antibody to the 15-17 kDa 
antigen of this bacterium. The authors suggest that this technique may be used as a 
diagnostic aid when only formalin fixed tissues are available.
As this very versatile technique can be used to localise almost any antigenic material it 
can also detect toxins produced by micro-organisms and be used to investigate the role of 
these substances in disease pathogenesis. For example, Whitely et al. (1990) used 
immunohistochemistry to localise Pasteurella haemolytica Al derived endotoxin, 
leukotoxin and capsular polysaccharide in experimental cases of bovine pasteurella 
pneumonia. The study aimed to localise the cellular and subcellular sites of interaction of 
endotoxin and leukotoxin in the lungs and relate this to the location of bacteria using 
immunohistochemistry and immunoelectron microscopy. The authors found that 
endotoxin was released into the inflammatory exudate and could cross the alveolar wall 
and that leukotoxin appeared to be specific for leukocytes.
Immunohistochemistry can offer rapid confirmation of the diagnosis in bacterial 
infections where bacterial isolation is slow, expensive or difficult. One such application is 
the diagnosis of Listeria monocytogenes infection by immunohistochemistry on fixed 
brain tissue (Weinstock, Horten and Rowland 1995). This group used commercially
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available rabbit polyclonal antiserum titrated using tissue from a sheep from which a pure 
culture of L. monocytogenes had been isolated. The authors concluded that with careful 
tissue selection (staining was best in microabscesses or areas of necrosis) that the 
technique was accurate and specific.
Haziroglu et al. (1996) used the immunoperoxidase method to investigate Mycoplasma 
ovipneumoniae and Pasteurella haemolytica antigens in pneumonic lungs of 2-10 month 
old lambs. Some discordance was found between the results of bacterial isolation and 
immunohistochemistry but the clear visualisation of antigen in the lesions was considered 
valuable in the study of respiratory disease pathogenesis. It was considered that positive 
isolations and negative immunohistochemistry might be due to low numbers of bacteria 
in the sections and the reverse effect might be due to immunohistochemical detection of 
antigen from non-viable bacteria.
iii)Prion-reIated Disease
Immunohistochemistry has also found application in the investigation of prion related 
diseases, for example natural scrapie in sheep. The diagnosis of scrapie classically rests 
on finding neuronal and neuropil vacuolation in the brains of clinically affected sheep. 
Problems arise when vacuolar change is absent or minimal in suspect cases or where 
vacuolation is observed in brains from apparently healthy sheep. Specialist techniques 
such as western blotting or electron microscopy may be used to investigate these cases 
but require specialist laboratories whereas immunohistochemistry can be used with 
relative ease and on fixed tissues. In 1993 Miller et al. described a protocol for 
immunohistochemical detection of scrapie associated prion protein (PrPsc). Due to the
nature of the fixation protocol used the sections examined in this study could not also be 
used for histopathologic scrapie diagnosis. In 1995 Van Keulen et al. refined this 
technique using a slightly different fixation protocol which better preserved tissue 
morphology and an autoclave pre-treatment step to enhance PrPsc immunoreactivity. 
Using antisera to ovine PrP Van Keulen and colleagues detected PrPsc in the brains of 
fifty sheep with natural scrapie. Brains from twenty control sheep were examined and 
found negative. The scrapie associated protein was found both in vacuolated areas and 
non-vacuolated areas of the brain. The authors concluded that the immunohistochemical 
detection of PrPsc was a useful confirmative test in scrapie diagnosis.
iv)Skin Disease
Immunohistochemistry has proven a useful technique for examination of the skin both in 
disease states and in the assessment of cell populations and cell activity in normal skin. 
One of the most common dermatopathological applications of immunohistochemistry is 
the investigation of immune mediated skin disease.
In an attempt to validate a more convenient method than immunofluorescence, and to 
improve on the previously reported PAP immunostaining on formalin fixed tissues (Suter 
et al. 1984) Haines, Cook and Clarke (1987) investigated the use of ABC 
immunohistochemistry with enzymatic antigen retrieval to detect intercellular IgG in the 
epithelium of formalin fixed skin biopsies from dogs with autoimmune skin disease. In 
their study, twenty-seven of twenty-eight cases diagnosed by histology as autoimmune 
skin disease (AISD) were positive by immunohistochemistry. One case of seven
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diagnosed histologically as not consistent with AISD also showed intercellular IgG 
staining consistent with pemphigus foliaceus.
Day, Hanlon and Powell (1993) reviewed a series of cases of immune mediated skin 
disease in the dog and cat with special reference to immunohistochemistry using species- 
specific IgG and IgM antibodies. Immunohistochemical staining of sections from ten 
dogs with pemphigus foliaceus showed intraepithelial deposition of IgG in seven cases, 
this was accompanied by IgM in two cases. The location of the positive staining was 
associated with dermal aggregates of B-cells/plasma cells. Eight biopsies from cats with 
pemphigus foliaceus were examined and only two of these showed intraepithelial IgG 
deposition. In the dog detection of the third component of complement (C3) was also 
attempted, with no positive results. Smaller numbers of other disease states were similarly 
examined.
In 1995, Gorrell, Townsend and Ladds examined the lymphocyte populations in normal 
and acanthotic ovine skin using an indirect immunoperoxidase technique on frozen 
sections. The authors found that acanthotic skin had an eight-fold increase in the number 
of lymphocytes in the epidermis and at the dermoepidermal junction. They also describe 
changes in the distribution of T-cell subsets.
The technique has also been used to characterise the immunophentype of the lesions in 
canine demodicosis. Caswell et al. (1995) reported that all the lymphocytes located within 
the follicular walls of biopsies from affected dogs were CD3+ T-lymphocytes, compared 
with the mostly plasma cell perifollicular infiltrate which contained only 10% CD3+ T-
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cells. The authors suggest that a cell mediated reaction which targets the follicular wall is 
involved in demodicosis.
This first chapter provides a technical overview of the principles and methods employed 
in immunohistochemistry and a review of the literature concerning the application of 
immunohistochemical methods in diagnostic pathology. From this it is clear that 
immunohistochemistry is of wide and increasing use in the investigation of animal 
disease.
In the following chapters immunohistochemical investigations performed by the author 
are described.
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Chapter 2
Thymoma: A Practical Challenge for Immunohistochemistry
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2.1.1) Thymoma: a practical challenge for immunohistochemistry.
Thymomas are tumours of the epithelial component of the thymus gland and are 
uncommon in most domestic species (Moulton and Harvey 1990, Theilen and 
Madewell 1987). Diagnosis of a thymoma hinges on the identification of an abnormal 
population of epithelial cells. These epithelial cells are, however, often obscured by 
lymphocytes and the use of immunohistochemistry can provide specific evidence of 
their lineage and allow an exact diagnosis whilst conventional techniques may only 
allow suspicion or tentative diagnosis in some cases.The differentiation of thymoma 
from the more common neoplasm of thymic lymphosarcoma presents a diagnostic 
challenge for the practical application of immunohistochemistry in veterinary 
pathology.
To assess the possibilities of the technique which, through the specificity of the 
antigen-antibody interactions involved, can definitively identify cell type, thymic 
tumour cases drawn from the Department of Pathology archive and active cases 
passing through the Veterinary Hospital system were examined.
To appreciate the types of thymic malignancies which may be encountered it is 
necessary to review the basic developmental biology of the thymus.
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2.1.2) The thymus.
Embryologically the thymus is a paired organ which develops from the ectoderm of 
the third brachial cleft and the endoderm of the pharyngeal pouch. These tissues 
migrate caudally as the foetus grows (Griffith 1990). In the young calf the thymus 
extends from the larynx to the pericardium and rapidly increases in size during the 
first 6-9 months of post natal life although it reaches its greatest relative size shortly 
after birth (Dyce, Sack and Wensing 1987). With age active lymphoid tissue is 
replaced by fat and fibrous tissue but this process is variable and is influenced by 
many factors including stress and infectious disease. In normal animals a thymic 
remnant is detectable throughout life.
The thymus is a composite of lymphoid and epithelial tissues, a lobulated, 
encapsulated organ divisible into cortex and medulla. It is a central (primary) 
lymphoid organ which plays a dominant role in T lymphocyte development. The 
epithelial stroma is established first and attracts lymphocyte precursors. T cells 
originate in the bone marrow but do not differentiate there. Instead, they migrate at an 
early stage to the subcapsular region of the thymic cortex and in this specialised 
microenvironment undergo differentiation, expansion and selection (Van Ewijik, 
1991, De Waal Malefit et al. 1986). Bone marrow derived macrophages also colonise 
the thymus along with lymphocyte precursors.
Because T lymphocytes recognise foreign antigen only in the form of peptides bound 
to self MHC molecules, to contribute to the immune response T cells must be able to 
identify the body's own MHC molecules. This is known as self-restriction. It is also
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critically important that they do not react to self-peptides bound to self MHC 
molecules - they must be self tolerant. It is in the thymus that T cells are selected to 
fulfil these two requirements (Roitt 1997). Through positive selection cells are 
screened for self MHC restriction and by negative selection cells which react to self- 
peptides bound to self MHC are eliminated. Although extensive proliferation of T 
lymphocytes occurs in the thymus the rigorous selection they undergo means that most 
die there by apoptosis (programmed cell death). Only approximately 2% of the 
developing thymocytes (thymic lymphocytes) will leave the organ as mature T cells 
(Janeway and Travers 1994). Ingenious experimental work involving transgenic mice 
has demonstrated that positive selection of thymocytes depends on thymic cortical 
epithelial cell MHC expression (Cosgrove et al. 1992, Moller 1993) whilst bone 
marrow derived antigen presenting cells (APCs) are most important in driving 
negative selection (Kappler, Roehm and Marrack 1987). These APCs are also 
responsible for presenting antigen to mature T cells in the body.
A varied and interacting population of cells therefore exists in the thymus. Of these 
the thymocytes are by far the most numerous and at least in the cortical areas tend to 
obscure the other populations on conventional microscopic examination.
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2.1.3) Tumours of the thymus.
As would be expected in any organ, tumours arising in the thymus can originate in any 
of the different cell types which make up that organ. In practical terms thymic tumours 
are likely to arise from the thymic lymphoid or epithelial cell populations. The relative 
prevalence and importance of these conditions in veterinary medicine is discussed 
below.
Thymic Lymphosarcoma
Thymic lymphosarcoma is particularly important in cattle where it is one of three 
major forms of Sporadic Bovine Leukosis (SBL). This condition is characterised by 
enlargement of the thymus by malignant lymphoid cells with variable involvement of 
the local nodes and bone marrow and is typically seen in animals less than three years 
of age, most frequently in those between six months and two years (Blood and 
Radostits 1989, Stober 1981). The other major manifestations of SBL are juvenile 
multicentric lymphosarcoma, which presents as multiple lymph node enlargement in 
animals less than six months old and the rarer cutaneous form where animals, usually 
between one and three years of age, develop plaques and nodules in their skin which 
regress and recur. Sporadic Bovine Leukosis is not associated with Bovine Leukaemia 
Virus (BLV) infection, the animals do not demonstrate antibodies to the virus and no 
viral DNA has been detected in the tumours (Ogawa et al. 1986).
Thymic lymphosarcoma is also an important disease in the cat. Lymphosarcoma 
(lymphoma) of all types is the most common tumour in this species accounting for
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one third of all tumour cases (Jarrett 1990). Thymic lymphosarcoma is diagnosed over 
a wide age range but is more prevalent in young cats (Moulton and Harvey 1990). 
Presenting signs are almost always due to space occupying effects of the primary 
tumour as although metastasis may occur this appears to be a late event and 
comparatively less important in the clinical course. Thymic lymphosarcoma in the cat 
is strongly associated with Feline Leukaemia Virus infection, 80% of cases are FeLV 
positive (Jarrett 1990).
Thymic lymphosarcoma is recognised in the dog but is uncommon. Theilen and 
Madewell (1987) reported less than 5% of their canine lymphoma cases to be of this 
type.
Thymoma
Bovine thymomas are extremely rare with only a few cases in the literature reported in 
any detail (Altman and Streett 1968, Parker and Casey 1976, Momotani, Nakamura 
and Shoya 1981). In some of the older veterinary literature the term thymoma was 
used to denote any tumour of thymic origin which can hamper interpretation in the 
absence of histological description.
In contrast to the bovine situation the most common thymic tumour in goats is 
reported to be the thymoma. These growths are especially prevalent in dairy breeds. 
One American study found 25% of goats necropsied at over two years old to have 
clinically silent thymomas (Hadlow 1978). A series of thymoma cases have also been 
reported in the Angora goat (Streett et al. 1968).
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In small animals there is a fairly extensive literature on thymic epithelial tumours. 
Thymomas are described in the dog (Robinson 1974, Bellah, Stiff and Russell 1983, 
Aronsohn 1985) and cat (Carpenter and Holzworth 1982, Martin et al. 1986, Gores et 
al. 1994) where they can be benign or malignant. Benign tumours may be 
asymptomatic or have space occupying effects but they are well encapsulated and do 
not invade locally. Malignant thymomas, however, spread by local invasion, 
transcoelomic seeding and through blood vessels and lymphatics with observed 
metastatic involvement of the lungs and liver. In human patients a number of 
autoimmune paraneoplastic syndromes are associated with thymoma and similar 
problems have been identified in the dog. Aronsohn et al. (1984) observed an 
autoimmune paraneoplastic syndrome in ten out of fifteen of a series of dogs with 
thymoma. Myasthenia gravis, hypercalcaemia and polymyositis have been identified 
in canine thymoma cases by several other authors (Darke, McCullagh and Geldart 
1975, Harris et al. 1991, Klebanow 1992). Feline thymomas are associated with 
similar syndromes of myasthenia gravis (Scott-Moncrieff, Cook and Lantz 1990) and 
polymyositis (Carpenter and Holzworth 1982).
Classification of thymomas
Several systems of classifying primary thymic tumours have been proposed for use in 
the field of human medicine. These have ranged from a simple division according to 
whether or not the tumours were associated with myasthenia gravis (Iverson 1956) to 
complex systems based on embryological origin (Lewenhaupt 1948). However, most 
classifications are based on the microscopic appearance of the tumour with the broad 
categories of epithelial, lymphoid and teratomatous variously subdivided. The term 
thymoma is now exclusively used for epithelial tumours of the thymus and it is widely
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agreed that this term should be restricted to tumours where the epithelial cells are 
cytologically benign (Castleman 1955, Levine and Rosai 1978, Rosai and Levine 
1976) although the behaviour of these tumours may be benign or malignant. Where 
the cells are cytologically malignant the growths are designated thymic carcinomas 
(Henry 1992). The histological appearance of the thymomas reported in the veterinary 
literature is quite variable including clear cell variants (Mackey 1975, Gores et al. 
1994) and cystic tumours (Gores et al. 1994). It is common to see a very variable 
cytological appearance in different fields of the same tumour. In human medicine, as 
the histological appearance of the cells is not a reliable reflection of biological 
behaviour, the appearance at thoracotomy of invasive growth or lack of it is the most 
important prognostic indicator (Batata et al. 1974, Walker, Mills and Fechner 1990).
Jarrett and Mackey (1974) in the World Health Organisation "International 
Histological Classification of Tumours of Domestic Animals" simply separate 
thymomas into two types; predominantly epithelial where the cells are mostly plump 
and elongate with abundant, faintly eosinophilic cytoplasm and predominantly 
lymphoid where the most abundant cells have the appearance of normal mature 
lymphocytes.
A fairly simple system which separates thymomas into mixed epithelial-lymphoid, 
predominantly epithelial, predominantly lymphoid, spindle cell and clear cell variants 
is probably most useful for these tumours in domestic animals in terms of histological 
description. No prognostic significance has been determined for these variants.
Differential diagnosis of thymic tumours
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The essential criterion for diagnosis of a thymoma is the identification of a population 
of neoplastic epithelial cells. This can be problematic as these cells are always 
accompanied by lymphocytes. Even in metastases the association between neoplastic 
thymic epithelium and lymphocytes is maintained. It is suggested that the tumour cells 
provide a microenvironment in which T-lymphocytes are induced to differentiate 
along normal pathways much as they are in the normal thymus (Henry 1992). In many 
cases the accompanying lymphocytes are far more numerous than the epithelial cells 
and may obscure them possibly leading to misdiagnosis as thymic lymphosarcoma.
Previously, differential diagnosis between thymic lymphosarcoma and thymoma has 
relied on the recognition of a second population of cells, distinct from lymphocytes in 
conventionally stained preparations. The lymphocytes found in a thymoma will be 
cytologically normal in contrast with the neoplastic lymphoid cells of a thymic 
lymphosarcoma. It is recognised that the appearance of the epithelial cells in a 
thymoma may be variable and commonly recognised patterns, such as spindle-shaped 
cells, "rosette" patterns and whorls reminiscent of abortive Hassall's corpuscles 
recapitulate patterns recognised during thymic development and involution (Lattes 
1962). Special histological stains have been employed to assist in the diagnosis of 
these tumours, for example staining for reticulin will tend to show no reticulin fibres 
between the cells (although this is not a constant finding) and the epithelial cells often 
contain PAS positive granules (Lattes 1962, Legg and Brady 1965).
Ultrastructural studies have also been carried out on these tumours. Using the electron 
microscope it is possible to demonstrate characteristically epithelial features; 
desmosomes and tonofilaments (Fukuda et al. 1992, Levine et al. 1975) in the
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thymoma cells. The drawbacks to this method are obviously the expense and lack of 
general availability of the use of an electron microscope.
In the field of human diagnostic pathology immunohistochemistry has been used as an 
aid to the diagnosis of thymic tumours. Antibodies to keratin have been used to 
demonstrate the epithelial nature of the neoplastic cell population in thymomas 
(Battifora et al. 1980).
Although histologically the critical distinction which can prove most difficult may be 
that between a thymic lymphosarcoma and a thymoma, in the clinical situation other 
neoplastic processes which may present as a cranial thoracic mass must also be 
considered as differential diagnoses. These include ectopic thyroid or parathyroid 
tumours, chemodectoma or other heart base tumour and primary lung tumours.
The following work was performed to assess the potential of immunohistochemistry 
in veterinary diagnostic pathology with particular reference to its use as a tool for the 
reliable diagnosis of thymomas in domestic animals.
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2.2.1) Antibodies for use in Veterinary Diagnostics
The purpose of this part of the study was to investigate the practical applications of 
immunohistochemistry in diagnostic veterinary pathology. To do this the array of 
commercially available antibodies were reviewed. A range of veterinary research 
antibodies available from Serotec, (Oxford, England), includes leukocyte 
differentiation antigens and immunoglobulins from several domestic species. 
However, these products are designed as research tools and are suitable in some cases 
for cryostat sections, flow cytometry, ELISA or immunoprecipitation but they are not 
effective on conventionally processed tissue. A wide range of antibodies which can be 
used on formalin fixed, paraffin embedded tissues are available from many sources 
(Dako, Glostrup, Denmark; Novocastra, Newcastle, England; Serotec, Oxford, 
England) but these are all designed for use on human tissue with a small number of 
exceptions in the form of products designed for use in experimental laboratory 
rodents. No data was available on the use of these antibodies in the veterinary context.
A review of the literature and the manufacturers data provided the starting point for 
the investigations which began on an empirical basis. The aim of the study was first of 
all to establish whether commercially available anti-human antibodies could be 
successfully applied to tissues from domestic animals and then to evaluate their 
possibilities in the particular field of tumour diagnosis.
Antibodies for investigation in this study were selected according to the following 
criteria:
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i) applicability to routinely processed tissue
ii) of potential benefit in the diagnostic situation
Antigens of interest to the diagnostic pathologist
Of particular interest were the intermediate filament markers which can allow more 
accurate classification of morphologically undifferentiated or otherwise difficult 
neoplasms and the lymphoid subclass (Cluster of Differentiation, CD) markers which 
may be used to establish the character and clonality of lymphoid cell populations.
As described in Chapter 1 the immunohistochemical staining procedures are fairly 
laborious and antibodies can be expensive so it is not practical in the diagnostic 
situation to subject any doubtful tumour to a battery of immunohistochemical tests. In 
the field of medical pathology diagnostic algorithms have been designed to direct the 
application of immunohistochemical markers to difficult cases. The approach is to use 
a limited panel of the most useful antibodies and to take the microscopic appearance 
of the tissue in standard H&E sections as the starting point from which the pathologist 
uses his experience to determine what the tumour may be and decides which tests to 
employ. For example, to establish whether a poorly differentiated tumour is of 
epithelial origin (carcinoma) or mesenchymal origin (sarcoma) the tissues would be 
stained with cytokeratin and vimentin and examined. With a suitable range of 
antibodies the exact diagnosis may be pursued further. Figure 2 is an example of a 
simplified diagnostic algorithm and was prepared with reference to antibody 
specifities on human tissue as detailed in Jasani and Schmid (1993).
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Figure 2. Diagrammatic algorithm illustrating how a panel o f  antibodies, including the 
intermediate filament markers, can be used in the identification o f  tumours. The tissue 
distribution o f  these markers is covered in the text to follow. See also Table 3.
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2.2.2 Cytoskeletal Components
To understand the role of intermediate filaments in the cell and hence their 
significance in immunohistochemistry it is necessary to review intermediate filaments 
in the context of the cellular matrix.
Eukaryotic cells possess a complex array of filamentous proteins which constitute the 
cytoskeleton (Junqueira, Cameiro and Long 1986). The pattern of expression of these 
is tissue specific and determines the properties of each cell type. These proteins 
interact with both the nuclear and cytoplasmic membranes and are involved in 
providing mechanical support and determining cellular architecture, in cell motility, 
mitosis and differentiation, cytoplasmic translocation and in the coupling of cell 
surface receptors to cellular responses.
The major components of the cytoskeleton are: microfilaments (actin filaments)
intermediate filaments 
microtubules (tubulin polymers) 
(lamins - nuclear matrix proteins)
Microfilaments are present in all cells but are most abundant and well organised in 
muscle. These actin filaments are associated with myosin in all functions which 
involve cell motility, again this mechanism is best developed in skeletal muscle. Actin 
microfilaments form localised aggregates which are widely distributed in the cell. The 
filaments are labile, capable of rapid assembly (from a cytoplasmic monomer pool)
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and disassembly (Toner and McCormick 1992). The assembly of actin polymers is 
controlled by an extensive family of actin binding proteins (Stryer 1988).
Microtubules are hollow, cylindrical structures of indeterminate length, formed from 
the assembly of macromolecular subunits of two similar 50 KDa protein subunits, a  
and p tubulin (Stryer 1988). These structures are also very labile, capable of 
lengthening by the addition of tubulin molecules. A state of equilibrium between 
assembly and disassembly may be established. Microtubule bundles form part of the 
mitotic spindle, are attached to individual chromosomes and control their movement 
during mitosis (Toner and McCormick 1992).
Intermediate filaments are mechanically strong, being polymerised from fibrous, not 
globular, protein subunits unlike actin filaments and microtubules. They are also 
chemically stable and highly insoluble (Steinert et al. 1982). Intermediate filaments 
are not believed to undergo rapid assembly and disassembly.
In addition, a family of nuclear proteins, the lamins, are ubiquitously present in cells. 
Within the lamin family are three main types of polypeptide which form part of the 
nuclear matrix and compose the fibrous lamina which is closely associated with the 
internal membrane of the nuclear envelope (Junqueira, Cameiro and Long 1986). 
Lamins have some sequence homology with intermediate filament proteins (Watt 
1992). Lamin assembly is heavily modulated by phosphorylation and these proteins 
are likely to be important in chromatin organisation in interphase and nuclear 
envelope breakdown during cell division (Krohne and Benavente 1986).
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Each of these filament types has been studied with regard to its possible pathological 
significance (Rungger-Brandle and Gabbiani 1983), but at present intermediate 
filaments appear to be of most interest and it is on these proteins that this discussion 
focuses.
The tumour protein expression profile usually reflects that of the cell of origin but 
exceptions exist (Corwin and Gown 1989). In some cases the unusual pattern of 
intermediate filament (co)expression in a tumour is of itself of diagnostic significance. 
For example, epitheloid sarcomas characteristically co-express cytokeratin and 
vimentin (Daimara et al. 1987).
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2.2.3 Intermediate Filaments
Intermediate filaments are so named because at 7-1 lnm in diameter they are 
intermediate in size between microfilaments (5-7nm) and microtubules (22-25nm). 
They are long filaments formed by the polymerisation of rod-shaped coiled coil 
molecules. There are five major groups of cytoplasmic intermediate filament which 
although identical morphologically are biochemically and immunochemically 
distinguishable (DeLellis and Kwan 1988). Each of these intermediate filaments 
shows a characteristic pattern of cellular distribution which is outlined in Table 3.
Techniques utilising monoclonal antibodies and recombinant DNA have identified a 
multigene family of proteins that form the intermediate filaments (Franke et al. 1978, 
Lazarides 1982). The expression of these proteins appears to be controlled by 
individual genes and follows a regulated pattern of cell differentiation.
In the embryo, recognisable intermediate filaments (cytokeratins) begin to occur in the 
late morula/early blastocyst stage in association with the formation of nascent 
desmosomal structures (Jackson et al. 1980). Class switching of intermediate filament 
expression in embryonic cells occurs during their differentiation (Holtzer, Biehl and 
Holtzer 1985).
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Intermediate Filament Tissue Molecular Weight (kd)
cytokeratin epithelial cells 40-68
desmin muscle 53
glial fibrillary acid glial cells 55
vimentin mesenchyme 57
neurofilament neurones 68,160, 200
Table 3. The distribution o f  intermediate filament expression in different cell types.
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2.2.4 Immunohistochemistry of Intermediate Filaments
Immunohistochemistry for vimentin, desmin and glial fibrillary acid protein (GFAP) 
is relatively straightforward as these proteins are composed of a single type of 
polypeptide. Neurofilaments and cytokeratins are more complex. The former group 
has three major proteins and the latter at least nineteen. Immunohistochemistry of 
cytokeratin subclasses will be considered in greater detail in Chapter 3.
A large volume of work using recombinant DNA techniques has revealed that all the 
intermediate filament proteins have a central region approximately 310-350 amino 
acids long arranged in a repeating heptad sequence. This region has a coiled-coil 
structure produced by the interaction of neighbouring a-helices. This central rod 
domain is divided into four segments by non-helical regions (Weber and Geisler 
1985). All classes of intermediate filament share two highly conserved consensus 
sequences at the beginning and end of the rod domain (Cadrin and Martinoli 1995). 
This region of the intermediate filament protein molecules is highly stable to autolysis 
and fixation-induced changes so in one sense is a useful target to raise antibodies 
against. Importantly however, because these regions are highly homologous between 
the different classes of intermediate filament such antibodies are prone to cross 
reaction. The exposed, non-helical amino terminal “head” and also non-helical 
carboxy terminal “tail” regions of the protein are more susceptible to the formation of 
cross linkages during fixation but are more specific to the intermediate filament class. 
These regions are highly variable in size and amino acid composition (Steinert, Steven 
and Roop 1985) and produce the immunological and functional specificity of the
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different classes of intermediate filament. Antibodies raised against epitopes in these 
regions often require the use of cryostat sections to avoid changes due to fixation or, 
in the case of routinely processed samples, the application of enzymatic or high 
temperature unmasking techniques to restore antigenicity to these sites (see Chp. 1).
When undertaking immunohistochemical investigations into intermediate filament 
expression it is important to recognise the difference between true antibody cross 
reaction and intermediate filament co-expression. Some antibodies, both polyclonal 
and monoclonal recognise conserved epitopes and react with more than one and 
sometimes with all intermediate filaments. Equally some cells, for example some 
tumour cells, do genuinely express more than one class of intermediate filament 
(Daimara et al. 1987).
In doubtful cases when the tissue under investigation shows positivity to more than 
one intermediate filament marker, for example cytokeratin and vimentin, several 
strategies may be employed to ascertain what the true picture should be. First and 
most simply the investigator should use different antibodies to the same determinant. 
Using this panel approach it is possible to demonstrate whether the questionable 
intermediate filaments are persistently identified, which suggests genuine co­
expression, or whether one particular antibody appears to be producing a spurious 
positive result which suggests cross reaction. Alternatively mRNA encoding 
intermediate filament proteins may be detected by in-situ hybridisation, demonstrating 
which proteins are being synthesised in the cell (Leube et al. 1986). Where strong 
staining for one intermediate filament is accompanied by weak, focal positivity for 
another cross reaction may be suspected, particularly if tissue pre-treatment has been
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carried out, as it is recognised that proteolytic pre-treatment, whilst often necessary, 
can generate spurious staining results (DeLellis and Kwan 1988). It is, of course, 
necessary to interpret all staining with reference to appropriate positive and negative 
controls (as outlined in Chp. 1). With many sections, a useful internal control is 
provided by examining normal structures such as skin or muscle within the section 
and rejecting sections where these elements are inadequately or incorrectly stained.
Cell cycle dependant changes in intermediate filament structure and distribution have 
been documented. Some changes in intermediate filament organisation are visible 
ultrastructurally but rearrangements at the subunit protein level, invisible to the 
electron microscopist, may affect reactivity with monoclonal antibodies (Franke et al. 
1983). This means that some antibodies which recognise an epitope only accessible 
during certain phases of the cell cycle, e.g. mitosis, may produce confusing results due 
to differential masking of the epitope rather than altered expression of the 
intermediate filament within the cell.
Another source of apparent conflict arises from the difference between antibodies for 
immunohistochemistry which must recognise the tertiary structure of proteins as they 
occur in the cell and antibodies for electrophoretic methods which require the 
denaturation of proteins. Antibodies are often raised against these denatured proteins 
and may react with epitopes unavailable in the cellular proteins (DeLellis and Kwan 
1988). Although commercially produced antibodies should have been thoroughly 
tested for reliable performance in all the systems for which they are marketed, internal 
quality control is very important, especially when antibodies are being applied to non­
human tissue for which little data is available.
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2.2.5) Other important immunohistochemical markers.
Just as the five classes of intermediate filaments are of great importance in tumour 
identification so are several other groups of antigens. In particular, the lymphoid cell 
markers known as CD antigens which allow immunological subdivision of lymphoid 
neoplasms are significant.
An enormous number of lymphoid markers exist. These are mostly antibodies against 
determinants on human cells and are usually highly species specific. These antibodies 
are organised into defined groups according to the decisions of international 
workshops. The antibody categories are established on the basis of their behaviour in 
three technical systems:
1) immunofluorescent cell surface labelling by Fluorescence Activated Cell Sorter 
(FACS)
2) immunoprecipitation of labelled cell surface antigens followed by analysis of their 
molecular weights
3) immunofluorescent or immunohistochemical staining of histological sections 
The tests are duplicated by independent laboratories before new antibodies are 
assigned to Cluster of Differentiation (CD) groups.
Many of these lymphoid antibodies are not applicable to routinely processed tissues as 
conventional processing destroys or alters the surface antigenic determinant which 
they recognise. The limited numbers of antibodies which are effective in fixed tissue 
are routinely used in human diagnostic pathology and include CD45 (LCA, Leukocyte
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Common Antigen) a pan-leukocyte marker which identifies all cells of haematopoietic 
origin, CD20 a pan B-cell marker (Mason et al, 1990) CD3 a pan T-cell marker 
(Engelman et al 1981) and CD68 a pan macrophage marker (Falini et al 1993).
Other markers of particular diagnostic interest are CD4 (helper/inducer T-cell 
specific) and CD8 (suppressor/cytotoxic T-cell specific) and antibodies to these 
determinants which are effective in paraffin sections are now being marketed by 
Novocastra, Newcastle, England.
Whilst in human diagnostic pathology immunohistochemical investigation of 
lymphoproliferative disorders is becoming an established and invaluable adjunct to 
classical morphological examination in the veterinary field the use of lymphoid 
markers is still very much restricted to specialised research applications. Only a few of 
the anti-human leukocyte antigen markers are of use in domestic animal species. The 
results of some investigations into the application of commercially available lymphoid 
markers in domestic animal tissues are presented later in this chapter.
Markers such as S-100, a protein expressed by tissue of neural crest origin which is 
particularly useful in detecting amelanotic melanomas, neuron specific enolase (NSE), 
an isoenzyme found in primarily in neurons and neuroendocrine cells and Factor VIII 
related antigen (FVIII-RAG)/von Willebrand factor which is expressed on endothelial 
cells and megakaryocytes are all potentially useful in the diagnostic context although 
they are not directly relevant to the study presented in this chapter.
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Thymic Tumour
epithelial m esenchym al
Figure 3. Simple diagramatic algorithm illustrating the selected range o f  
immunohistochemical markers applied to the tissues in this study.
m uscle
B cell T cell
Investigation
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2.3.1) Materials and Methods
The archive records of the Department of Pathology were examined for possible 
thymoma cases and the stored microscope slides and blocks were retrieved. Where 
necessary fresh H&E stained sections were prepared and the tumours were examined 
by routine light microscopy. Tissues judged to be severely autolytic were rejected.
Although the figures in Table 4 relate to the computerised records of the hospital 
system (dating from 1988) from which it is possible to obtain numerical totals some 
older cases of thymic tumours and some from external sources were available and 
these were also considered.
Six canine, three feline, one bovine and one caprine putative thymomas were 
examined. The antibody panel selected is illustrated in Figure 3. In addition sections 
of normal thymus from a young pup, a kitten and a young calf were processed using 
the same protocol. To provide further control sections for the lymphoid markers 
bovine and human tonsil and canine and feline lymph node were also stained with 
these antibodies.
Immunohistochemical Method
Formalin fixed, paraffin embedded sections of the eleven tumours and the normal 
control tissues were cut at 5pm onto microscope slides coated to promote tissue 
adhesion (APES: 3-aminopropyltriethoxysilane). This is necessary for sections which 
are to undergo the fairly vigorous and prolonged processing involved in 
immunohistochemistry.
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T h e fo llo w in g  a n tib od ies w ere  u sed  o n  the tissu e  section s:
CYTOKERATIN Dako, Glostrup, Denmark
MNF116, mouse anti-human monoclonal, isotype IgGl kappa
This antibody recognises cytokeratin sub-families 5,6,8,17,19 and has a broad pattern
of reactivity in epithelia. It may be used to detect normal and neoplastic cells of
epithelial origin.
VIMENTIN Dako, Glostrup, Denmark
V9, mouse anti-swine monoclonal, isotype IgGl kappa
This antibody cross reacts with human vimentin and labels cells of mesenchymal 
origin.
DESMIN Dako, Glostrup, Denmark
DE-R-11, mouse anti-swine monoclonal, isotype, IgGl kappa
This antibody is prepared using antigen purified from swine stomach and cross reacts 
with human desmin. It labels smooth and striated muscle.
CD3 Dako, Glostrup, Denmark 
rabbit anti-human polyclonal
This antibody is produced using synthetic human CD3 peptide coupled to bovine 
serum albumin as an immunogen. It is used as a pan-T cell marker in the detection of 
normal and neoplastic T cells.
CD79a Dako, Glostrup, Denmark
HM57, mouse anti-human monoclonal, isotype IgGl kappa
This antibody is raised using synthetic human CD79a peptide as an immunogen and 
detects an intracytoplasmic epitope in both normal and neoplastic B cells. It is known 
to cross react with B cells of many mammalian species.
Within the laboratory in the Department of Pathology we have considerable 
experience in using the cytokeratin, vimentin and desmin antibodies listed above. 
These have been extensively tested in the laboratory on a wide range of species and 
are known to work reliably on animal tissue. The use of the lymphoid markers is a 
newer development hence the requirement for staining human control tissue to ensure 
adequate processing and use of the domestic animal lymphoid tissue where the 
distribution of B and T lymphocytes is known as controls.
Enzymatic pre-treatment (see Chapter 1) using 0.1% trypsin with 0.1% calcium 
chloride in tris-buffered saline for thirty minutes at room temperature was employed
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to unmask antigenic sites before the use of the cytokeratin and desmin antibodies. In 
the case of the CD3 and CD79a antibodies heat mediated antigen retrieval using a 
pressure cooker (as described in Chp.l) was employed. For this 1600ml of citrate 
buffer was brought to the boil in a pressure cooker with the lid unlocked. The sections 
were immersed in the boiling liquid, the lid locked and the appliance allowed to 
pressurise (approx. 4min). The sections are then held at pressure for one minute. The 
vimentin antibody is effective on paraffin section without pretreatment.
Subsequent quenching of endogenous peroxidase activity (1.5% hydrogen peroxide in 
methanol for ten minutes) was carried out.
After this the slides were placed in a humidity chamber and the tissue sections ringed 
using a PAP pen (Miles Ltd, Stoke Poges, England) which produces a waxy line and 
creates a small well around the section into which solutions may be pipetted. At this 
stage all the sections were covered with PBS buffered pre-immune serum from the 
same species in which the secondary antibody was raised. This helps to prevent non­
specific binding of the antibody to immunologically “sticky” sites and hence reduces 
background staining. In this case rabbit serum was used and the sections incubated for 
thirty minutes.
Incubation with the antibodies listed above was carried out for sixty minutes at room 
temperature in the humidity chamber. Following test serial dilutions the cytokeratin 
and desmin antibodies were used at a dilution of 1:50, the vimentin at 1:40, the CD3 
at 1:200 and the CD79a at 1:500. During this time the negative control samples 
continue to incubate in the pre-immune serum.
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Following antibody incubation the sections were rinsed in TBS and processed 
according to a standard avidin-biotin peroxidase detection method (Vectastain, 
Vector Laboratories, Peterborough, UK.). The biotinylated secondary antibody (rabbit 
anti-mouse IgG) was applied and the sections incubated for thirty minutes.
A further five minute rinse was followed by thirty minutes incubation with an avidin- 
biotin-peroxidase complex, a similar rinse and incubation with a peroxidase substrate 
solution.
DAB (3,3-diaminobenzidine) was used as the chromogen and the sections were 
counterstained with Meyer’s haematoxylin. A ten minute incubation with the DAB 
was found to be adequate. The negative controls where the primary antibody was 
replaced by buffered serum were processed with the test sections.
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2.4.1) Results 
Archival Survey
When the archive of the Pathology Department at Glasgow University Veterinary 
School was reviewed for cases of thymic neoplasia thymic lymphosarcoma was by far 
the most common thymic neoplasm encountered. The results of the survey of the 
computerised database (which dates back to 1987) for canine, feline and bovine 
tumours are presented in Table 4. Examination of the records for caprine cases 
revealed only twenty cases in total and the only neoplasm identified in this group was 
the single thymoma described (Case 11).
The age distribution of cases of bovine thymic lymphosarcoma diagnosed in the 
Department of Pathology at Glasgow Veterinary School is in close agreement with 
published figures (see 2.1.3) and is illustrated in Figure 4 whilst the ages of the 
published thymoma cases (where supplied) are shown in blue in Figure 5. The purple 
marker in this figure represents the bovine thymoma described in this series (Case 10) 
which is the only such tumour recorded in the Pathology Department archives.
Figure 6 graphically displays the age distribution of feline thymic disease. Thymic 
lymphosarcoma has been seen at GUVS very much as a disease of young cats with the 
vast majority of cases being two years old or less. Nine cases of thymic 
lymphosarcoma included in Table 4 were from animals of unrecorded age. Of the 
three thymomas two were diagnosed on aged cats, the third cat was six years old.
In Figure 7 the age range of the canine thymic tumour cases is similarly illustrated. 
The pattern of disease in this species is quite different with the peak incidence of
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thymic lymphosarcoma in mature adult dogs and a greater overlap in age at 
presentation for lymphosarcoma and thymoma. As can be clearly seen from Table 4 
thymomas in the dog account for a far greater proportion of thymic neoplasms than is 
the case in the cat. One canine thymoma case was from an animal of unrecorded age.
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Pathology Database
All
Tumours
All
Thymic
Tumours
Thymic
Lymphosarcoma Thymoma O th e r  thym ic tum ours
Dog 4086 36 24 9 3
Cat 705 57 54 3 0
Cattle 867 59 58 1 0
Table 4. Numbers o f  thymic tumours in the computerised record o f  Glasgow  
Veterinary School. O f the canine tumour cases 0.59% were thymic lymphosarcomas, 
0.22% were thymomas. The feline tumour set contained 7.66% thymic 
lymphosarcomas and 0.42% thymomas and the bovine tumours included 6.67%  
thymic lymphosarcomas and 0.11% thymomas. See also Figures 3, 4, 5 and 6.
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BOVINE THYMIC LYMPHOSARCOMA [58 cases]
□ incidence
18 24
AGE[months]
Figure 4. Age distribution o f  bovine thymic lymphosarcoma cases seen at Glasgow  
University Veterinary School.
Bovine Thymomas
Recorded Ages O
tm
-Q
£
33
thymic lymphosarcoma
AGE (years)
Figure 5. Ages o f  thymoma cases (where recorded) in comparison with age 
distribution o f  thymic lymphosarcoma cases from Pathology Department archive.
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Figure 6. Graph o f  feline thymic tumour cases against age (where recorded).
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Figure 7. Graph illustrating the rather different age distribution patterns o f  the two  
types o f  thymic neoplasia examined in the dog.
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2.4.2) Results of immunohistochemical staining and case details
Standard H&E sections from the thymus of a young dog, a kitten and a calf were 
prepared and examined. In each the organ was densely cellular with clear lobulation 
and corticomedullary distinction. The cortex appeared to be composed almost entirely 
of closely packed lymphoid cells and the medulla was less densely cellular with some 
larger epitheloid cells visible along with the thymocytes (Figure 8).
The normal thymus sections were also stained with the broad spectrum cytokeratin 
antibody as described in the method. This effectively highlighted the cortical epithelial 
cells which are otherwise obscured by the lymphoid population. In the thymic medulla 
the epithelial population is also stained by this technique. The DAB chromogen gives 
rise to a brown pigment in the positive areas and this can be seen against the blue 
haematoxylin background stain in Figure 9.
When stained with the CD3 antibody there was little positivity amongst the immature 
thymocytes of the cortex. Towards the medulla more cells stained but the results were 
rather pale. Small numbers of CD79a positive B cells were identified in the cortex.
In both the human and animal tonsil and lymph node controls there was strong staining 
of the cells of the paracortex and scattered cells of the follicular germinal centres with 
the CD3 antibody. Staining of the follicular mantle, some cells in the germinal centre 
and scattered cells throughout the paracortex was produced with the CD79a antibody.
See Tables 5 and 6 for clinical, histological and immunohistochemical case details.
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Figure 8. Normal calf thymus. Note the distinct lobulation, densely cellular 
cortex and paler medulla in centre o f  lobule. H&E (medium power)
Figure 9. Normal calf thymus. The finely dispersed brown staining highlights 
the inconspicuous epithelial cells o f  the cortex whilst the medulla shows more 
prominent positivity for the epithelial marker. Broad-spectrum cytokeratin 
(medium power)
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Case 1.
Case one was an eleven year old female neutered Golden Retriever. She was suffering 
from a hepatocellular tumour and had just begun chemotherapy when she died in renal 
failure. The thoracic mass was discovered post mortem. At necropsy the animal was in 
poor body condition and ascitic. The liver had a hepatocellular tumour in the right 
middle lobe and was chronically congested. The thymic mass was roughly tubular and 
12x2x2cm in size. There was no significant cardiac pathology and the thymic mass 
was judged to be causing venous compression. The renal changes were those of acute 
tubular nephrosis and may have been related to chemotherapy.
Examination of the H&E section showed a vascular mass of moderate cellular density. 
The cells were of variable appearance, round to spindle shaped with variably sized 
vesicular nuclei. Intermixed with these cells was a population of smaller lymphoid 
cells. Sirius red staining revealed abundant stromal collagen.
Immunohistochemical examination with anti-cytokeratin antibody showed small nests 
of epitheloid cells to be very strongly stained (Figure 10). Many spindle cells were 
stained with vimentin (stromal fibroblasts). The tumour was uniformly negative for 
desmin and CD79a whilst very numerous CD3 positive cells were present throughout 
the section.
The diagnosis in this case was confirmed to be thymoma.
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Case 2.
Case two was a seven year old male crossbred dog which presented with a cough and 
a history of regurgitation. The dog was deteriorating clinically and megaoesophagus 
was detected so euthanasia was performed. At necropsy a firm, lobulated red mass 
6x5x5xcm in size was discovered just cranial to the heart. The oesophagus was dilated 
cranial to the level of this mass.
The H&E section from this tumour showed an extremely vascular tissue composed of 
mainly spindle shaped cells with oval to fusiform hyperchromatic nuclei forming a 
densely cellular network around numerous blood filled channels.
Immunohistochemical staining resulted in almost all cells staining positive with the 
cytokeratin marker (Figure 11). Only an occasional cell stained positive with vimentin 
and the section was completely negative for desmin and CD79a. Immunostaining with 
the CD3 marker highlighted a population of T-lymphocytes which were more difficult 
to identify in conventional sections.
This case was confirmed to be a thymoma.
Case 3.
Case three was a ten year old female Golden Retriever who presented with a history of 
regurgitation, dyspnoea, tachypnoea and exercise intolerance. A diagnosis of 
mediastinal neoplasia was made and the dog was euthanased. At necropsy a firm, 
white, nodular mass with cystic areas 18x15x12cm in size was found in the 
mediastinum. The left cranial lung lobe was extensively adhered to the mass and the 
thoracic oesophagus was flaccid and thin walled.
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Figure 10. Canine thymoma (case 1). Note groups o f  strongly stained epithelial 
cells. Broad-spectrum cytokeratin (medium power)
Figure 11. Canine thymoma (case 2). Almost all cells in this mass are stained.
Broad-spectrum cytokeratin (medium power)
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Microscopic examination of H&E stained sections showed an encapsulated mass 
divided by connective tissue septae and containing some cystic areas. The cells were 
of variable appearance, there were large numbers of clear cells and streams of cells 
with round nuclei and densely eosinophilic cytoplasm.
Immunohistochemically, most cells in this mass stained positive with cytokeratin. 
Many, mostly spindle shaped cells stained positively with vimentin, particularly in the 
connective tissue septae. No desmin positivity was detected but small foci of CD79a 
positive cells with a granular staining pattern were seen. Large numbers of CD3 
positive cells were present throughout the section.
Case three was also confirmed as a thymoma.
Case 4.
Case four was a nine year old male Irish Setter first presented nine months before 
euthanasia with a two month history of coughing and dyspnoea. Thoracic tumours 
were diagnosed radiographically and the dog was managed on diuretic therapy to 
control the associated hydrothorax. Thoracotomy was performed and a loculated 
cystic tumour observed in the anterior thorax and the dog euthanased. At necropsy the 
thoracic tumour was found to be very large, filling the anterior thorax completely and 
displacing the lungs dorsally and caudally. The mass was lobulated, mostly composed 
of firm white tissue but with cystic haemorrhagic areas.
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On H&E section this densely cellular mass was shown to be encapsulated and divided 
by connective tissue septae. A mixed population of lymphoid and larger round cells 
with eosinophilic cytoplasm was observed (Figure 12).
With cytokeratin immunostaining the dominant larger cell population was strongly 
positive (Figure 13). Occasional vimentin positive cells were observed, no desmin or 
CD79a positivity was detected and very large numbers of lymphoid cells were CD3 
positive.
The immunohistochemical results confirmed the diagnosis of thymoma.
Case 5.
Case five was a five year old neutered male Boxer. He presented with a history of 
dullness, vomiting, diarrhoea and occasional dyspnoea over one to two months. 
Ultrasound examination revealed a thoracic mass and pleural effusion. The dog was 
euthanased. At necropsy he was found to be in good body condition and to have an 
anterior mediastinal mass displacing the heart and lungs. The mass was firm and white 
with haemorrhagic areas and surrounded the trachea and oesophagus.
Microscopic examination of H&E sections of this mass showed a moderately heavy 
stroma dividing sheets of round cells with large round nuclei and moderate amounts 
of eosinophilic cytoplasm.
These cells were uniformly negative for cytokeratin and desmin expression. Many 
spindle cells were vimentin positive and scattered CD79a positive cells were present 
in some areas. There were widely distributed CD3 positive cells.
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Figure 12. Canine thymoma (case 4). A mixed population o f  small lymphocytes 
and larger eosinophilic cells can be seen. H&E (medium power)
Figure 13. Canine thymoma (case 4). With cytokeratin immunostaining there
is widespread positiv ity o f  the larger cells. Broad-spectrum cytokeratin (medium
power)
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As the cells of this mass were negative for cytokeratin the original diagnosis of 
thymoma was found to be incorrect (see discussion).
Case 6.
Case six was an eight year old male Labrador Retriever which presented with sudden 
onset respiratory distress. Ultrasonic and radiographic examination showed a very 
large thoracic mass caudally displacing the heart. The dog was euthanased without 
further investigation or treatment. At necropsy the large thoracic mass was found to be 
firm and white with central haemorrhage and areas of necrosis. The heart was caudally 
displaced and the lungs partially collapsed. A small quantity of fluid was present in 
the pleural cavity.
On H&E section the mass was clearly composed of a mixed population of cells 
containing large paler staining epithelial-type cells and numerous small lymphocytes 
(Figure 14).
Immunohistochemical staining with cytokeratin effectively highlighted the population 
of larger cells, confirming their epithelial origin (Figure 15). Vimentin and desmin 
immunohistochemistry yielded negative results. Staining with the T cell marker CD3 
produced positivity in many, but not all of the small lymphocytes (Figure 16). These 
negative cells were also unstained with CD79a as shown in Figure 17 (see 2.5.1).
Case six was confirmed as a thymoma.
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Figure 14. Canine Thymoma (Case 6). The mass is composed o f  a mixture 
epitheloid cells and smaller normal lymphocytes. H&E (high power)
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Figure 15. Canine Thym om a (Case 6). The larger cells are strongly stained
whilst the lymphocytes are unstained. Broad spectrum cytokeratin (high power)
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Figure 16. Canine Thymoma (Case 6). Many, but not all the lymphocytes, are 
positive with this T-cell marker. CD3 (high power)
Figure 17. Canine Thymoma (Case 6). No cells are positive with the pan-B 
marker. CD79a (high power)
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Case 7.
Case seven was a seven year old male neutered Domestic Shorthair cat which 
presented with a three month history of coughing, tachypnoea and hyperpnoea. Minor 
weight loss was also reported. Radiologically a thoracic mass was visualised. 
Thoracotomy was performed and the mass removed and submitted for histological 
examination. The mass was firm, white and lobulated measuring 7x4x4cm with a 
cystic centre.
On H&E section this mass was composed of admixed sheets of lymphoid and larger 
round cells which tended to aggregate together. Some fields were composed almost 
exclusively of lymphoid cells.
On immunohistochemical examination with cytokeratin there were numerous 
interlinked cords and clusters of strongly stained cells against a background of 
unstained lymphoid cells. The tissue was negative for desmin, had very few vimentin 
positive cells and widely distributed CD79a positive cells. These, however, were 
greatly outnumbered by CD3 positive cells.
This case was also confirmed to be a thymoma.
Case 8.
Case eight was a neutered male Domestic Shorthair cat of unrecorded age. When the 
cat was presented for routine vaccination the veterinary surgeon noticed displacement 
of the cardiac sounds with no thoracic fluid apparent. Radiography confirmed the
115
presence of a cranial thoracic mass and a needle biopsy was taken and sent to the 
Department of Pathology.
H&E sections of this good quality needle biopsy showed small fragments of tissue 
composed of admixed lymphoid and larger oval to spindle shaped cells with oval 
nuclei (Figure 18).
On immunohistochemical staining with cytokeratin the larger cells were strongly 
stained with cytokeratin and the lymphoid cells were clearly unstained (Figure 19). 
The sample was negative for vimentin and desmin. Foci of CD79a positivity were 
identified and numerous, strongly stained CD3 positive cells were present.
The biopsy diagnosis of thymoma was demonstrated to be correct for this case.
Case 9.
Case nine was a sixteen year old female neutered Domestic Shorthair cat which was 
on treatment for hyperthyroidism (carbimazole). The animal developed massive 
oedema and pleural effusion and was euthanased with a diagnosis of congestive 
cardiac failure. Post mortem examination revealed a very thin carcase with turbid, 
malodorous fluid in both the thoracic and abdominal cavities. A calcified mass was 
present in the mediastinum. Its origin was uncertain. Pasteurella multocida was 
cultured from the thoracic fluid.
This necropsy specimen had large amounts of mineralisation which had produced 
scoring when the sections were cut. Sheets and shreds of vascular, densely cellular 
tissue composed of spindle shaped cells with round to oval nuclei were observed.
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This tissue was completely negative for cytokeratin. When stained with the vimentin 
antibody moderate numbers of cells were positive. No CD79a positivity was present 
but CD3 positive cells were numerous in some areas.
As no cytokeratin positivity was demonstrated in this mass the diagnosis of thymoma 
was rejected.
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Figure 18. Feline thymoma (case 8). Note the mixture ot lymphoid cells and
larger, paler staining epithelial cells. H&E (medium power)
Figure 19. Feline thymoma (case 8). The brown colour highlights the epithelial 
cells whilst the lymphocytes are stained blue by the haematoxylin counterstain. 
Broad-spectrum cytokeratin (medium power)
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Case 10.
Case ten involved a six year old Ayrshire cow with a six week history of neck and 
foreleg swelling unresponsive to treatment with antibiotics and corticosteroids which 
was referred with an initial diagnosis of Adder bite. The cow was non-pregnant and 
nearing the end of lactation. Her rectal temperature was 38.6°C, heart rate 80bpm with 
the cardiac sounds muffled and caudally displaced and respiratory rate 20pm with an 
occasional cough. There was a poorly defined, palpably irregular mass at the thoracic 
inlet, pre-stemal oedema and jugular distension. No sign of thoracic pain was evident 
on percussion. The prescapular lymph nodes were enlarged but other palpable nodes 
were of normal size. On arrival she had diarrhoea and later developed rumenal bloat. 
A tentative diagnosis of thymic neoplasia was made and the cow was euthanased due 
to a worsening tendency towards rumenal bloating. At necropsy the animal was found 
to be in reasonable body condition. Figure 20 shows her thoracic viscera plus the firm 
yellowish white, nodular thymic mass of 40x3 5x30cm in size which was compressing 
and caudally displacing the heart and lungs. Tumour tissue extended into the cervical 
and mediastinal lymph nodes which were massively enlarged and over the pleural 
surface of the first five ribs. The tumour mass was located in the position of the 
thoracic thymus and no normal remnant of this organ could be detected. There was 
marked oedema with lymphatic dilatation and perilymphatic fibroplasia in the 
prestemal area. In the abdomen the rumen was found to contain a small amount of 
dry, firm material and to be massively distended with free gas.
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Figure 20. Thoracic viscera from case 10. Note large yellowish mass cranial 
to heart (cut surface shown). A small area o f  necrosis is present near the top 
edge.
Figure 21. Bovine thymoma (case 10). The mass shows variably sized cells 
in a heavy connective tissue stroma. H&E (medium power)
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On H&E section this mass was moderately cellular with prominent stromal collagen. 
There was a mixture of cell sizes, the smaller cells had round dense nuclei and the 
larger ones vesicular nuclei with indistinct cytoplasm (Figure 21).
When examined with anti-cytokeratin antibody the mass showed widespread 
positivity with a degree of background staining (Figure 22). With vimentin a 
population of spindle cells stained positive whilst the vast majority of cells remained 
unstained. Desmin staining was negative whilst a few cells were positive for CD79a. 
CD3 staining highlighted a population of lymphoid cells which were more numerous 
than expected from the conventional sections.
Immunohistochemistry confirmed the diagnosis in this case to be thymoma.
Case 11.
Case eleven was a four year old female Saanen goat which was euthanased because of 
chronic wasting. At necropsy the animal was observed to be in poor body condition. A 
firm, lobulated, creamy-yellow mass was found lying cranial to the heart. This tumour 
filled the thoracic inlet and is illustrated in Figure 23.
Microscopic examination of H&E sections of this mass revealed it to be densely 
cellular with prominent connective tissue septae. It had a mixed population of small 
lymphocytes and larger cells with vesicular nuclei and moderate amounts of 
eosinophilic cytoplasm (Figure 24).
The larger cells which were the dominant population stained strongly with the anti- 
cytokeratin antibody (Figure 25). Vimentin staining yielded multifocal positive
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staining of fibroblasts. Desmin and CD79a staining were negative whilst large 
numbers of cells were CD3 positive.
Immunohistochemistry was effective in confirming the histological diagnosis of 
caprine thymoma.
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Figure 22. Bovine thymoma (case 10). Most o f  the cells stain with antibody 
to cytokeratin. Background staining is also apparent. Broad-spectrum cytokeratin 
(medium power)
Figure 23. Thoracic viscera from case 11. Note lobulated yellowish mass over 
heart in anterior thorax.
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Figure 24. Caprine thymoma (case 1 1). A mixed population o f  cells are seen 
in a prominent connective tissue stroma. H&E (medium power)
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Figure 25. Caprine thymoma (case 1 1). The larger epithelial cells are strongly 
positive and the lymphocytes negative. Broad-spectrum cytokeratin (medium 
power)
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cytokeratin vimentin desmin CD3 CD79a
Case 1 ++ + - +++ -
Case 2 ++++ (+) - + -
Case 3 +++ + - +++ (+)
Case 4 +++ (+) - +++ -
Case 5 - ++ - ++ +
Case 6 +++ - - ++ -
Case 7 ++ (+) - +++ +
Case 8 +++ - - +++ +
Case 9 - ++ - + -
Case 10 ++++ + - ++ -
Case 11 +++ + - +++ -
Table 6. Tabulation o f  immunohistochemistry results for tumours tested.
++++ majority o f  cells stained
+++ large numbers o f  cells stained
++ moderate numbers o f  cells stained
+ small numbers o f  cells stained
(+) occasional cells stained
- no positive cells
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2.5.1) Discussion
From this small survey, five out of six canine cases (cases 1-4 &6), two out of three 
feline cases (cases 7 and 8), the bovine and the caprine case (cases 10 and 11) were 
confirmed as thymomas using immunohistochemistry. In some cases the appearance 
of the cells by conventional staining alone was highly suggestive of this diagnosis but 
in others the nature of the cells was not clear nor was their distribution throughout the 
tumour mass. In all the positive cases the use of anti-cytokeratin antibodies was 
effective in highlighting the epithelial cells with an unequivocal difference between 
the positive and negative populations. In the negative cases there was no trace of 
cytokeratin positivity. In cases 5 and 8 vimentin positivity was present in moderate 
numbers of cells and these tumours are likely to be sarcomas.
In each case negative control samples were carefully examined to exclude the 
possibility of non-specific binding. This was not found to be a problem with any of 
these sections. There was, however, variation in intensity of cytokeratin staining 
between the thymomas which is likely to relate to variations in fixation time and 
levels of intermediate filament protein expression. The bovine tissues examined 
tended to produce some background staining on the test sections and the author has 
observed this to be a common occurrence in this species with a variety of antibodies 
and techniques.
As listed in Table 5, the predominant clinical findings in those cases subsequently 
shown to be thymomas were respiratory. Dyspnoea and coughing will have been due 
to space occupying effects of the thoracic tumour masses. In cases 5 and 8 where the
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final diagnosis was not thymoma the clinical syndromes were also different: vomiting 
and diarrhoea in one case and congestive cardiac signs in the other.
The results of the CD3 immunostaining were interesting. This antibody identified 
populations of T cells accompanying the epithelial cells in all the thymoma cases and 
the lymph node and tonsil controls but produced little staining in the sections of 
normal thymus. In humans the CD3 molecule (also referred to as TCR or T cell 
receptor) is expressed during thymopoesis, although not during the very early stages 
of T cell maturation, as well as on mature T cells (Petrie et al. 1990). However, many 
"double positive" thymocytes, slightly more mature cells which express both CD4 and 
CD8 express only low levels of CD3 (Janeway and Travers 1994) with only those 
which successfully recognise self-MHC and pass the positive selection criteria going 
on to express high levels of CD3 (and ceasing to express one of the co-receptor 
molecules to become "single positive"). In case 6 it was particularly obvious that a 
population of lymphocytes were present which did not stain for CD3 or CD79a. It is 
quite possible that these cells are less mature members of the T cell series. The results 
on the tumours and on the peripheral lymphoid tissue control sections strongly support 
the assertion that this antibody is appropriate for detection of mature T lymphocytes in 
domestic animals. Examination of suspensions of labelled thymic cells from these 
species by fluorescence activated cell sorter (FACS) would provide a more accurate 
measure of their receptor status but these results may be consistent with low level 
expression in many cells which is not effectively demonstrated by 
immunohistochemistry.
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The criterion for the diagnosis of thymoma is the demonstration of an abnormal 
population of cytologically benign epithelial cells (Castleman 1955, Rosai and Levine 
1976, Levine and Rosai 1978). All the cases described as positive here fulfil this 
criterion. Cytological indices of malignancy; nuclear and cellular pleomorphism, 
increased nuclear to cytoplasmic ratio, nuclear hyperchromatism and abnormal 
mitoses were not present.
This was also true for the single case of bovine thymoma reported by Altman and 
Streett (1968) and the fifteen cases (6 canine, 1 feline, 5 bovine and 3 ovine) in the 
series described by Parker and Casey (1976). However, in the more recent report by 
Momotani, Nakamura and Shoya (1981) a single case of bovine thymoma is reported 
where the epithelial cells are described as resembling squamous epithelial cells with 
1-3 large nuclei and conspicuous nucleoli. These cells were very variable in size, 
shape, nucleus to cytoplasm ratio and staining characteristics. This tumour, although a 
commonly quoted example of bovine thymoma, had the morphologic appearance of a 
carcinoma (it also had distant metastases) and would more properly be described as a 
thymic carcinoma under current classification (Henry 1992).
The caprine cases in Hadlow's survey (1978) were all composed of a mixture of 
cytologically bland epithelial cells and normal lymphocytes, as were the caprine and 
most other cases in this survey. From Hadlow’s series, in sixteen out of seventeen 
thymomas normal lymphocytes were the most numerous cells.
The benign cytological appearance of thymomas is not a reliable guide to their 
biological behaviour. In the human literature the presence or absence of invasion 
through the tumour capsule at thoracotomy is considered to be the major factor
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separating functionally malignant and benign thymomas (Batata et al. 1974, Walker, 
Mills and Fechner 1990). Aronsohn (1985) proposes a classification for canine 
thymomas based on the human literature. He divides thymomas into grades I-IV 
where grade I tumours are completely bounded by their capsule, grade II tumours 
show pericapsular invasion into fat and serosae, grade III tumours have invasion into 
neighbouring organs and/or intra thoracic metastases and grade IV tumours exhibit 
extra-thoracic spread. These grades of tumour are separable in prognostic terms and 
require different therapeutic approaches. Suitable treatment modalites are suggested.
For the cases described here the information required to grade the tumours 
prognostically as described by Aronsohn (1985) is not consistently available. It would 
seem that whilst his grading system is useful and relevant to the surgeon exploring a 
thoracic mass and may aid in management decisions regarding a case it cannot be 
readily applied to small biopsy samples. Broadly, the tumours examined in this study 
would fall into groups I or II in Aronsohn's classification.
What is clear from this study is that immunohistochemical examination of these 
tumours greatly facilitates histological classification. For example in the bovine case 
(case 10) it was difficult to classify the cells at all in the conventional H&E section. 
Most cells were then found to be epithelial through their cytokeratin positivity and 
CD3 staining highlighted a small but significant lymphoid component to the tumour. 
In some cases, particularly those where the cellular preservation was particularly 
good, as in Case 7, the immunohistochemical results confirmed the histological 
diagnosis.
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The results of this study indicate that immunohistochemistry is an effective and 
convenient way of identifying the epithelial nature of these thymic tumours. It allowed 
the definitive diagnosis of what is an extremely rare tumour in the bovine in a manner 
not previously reported. Previous attempts to confirm the epithelial nature of such 
neoplasms have employed electron microscopy to demonstrate epithelial features such 
as desmosomes and tonofilaments ultrastructurally (Momotani, Nakamura and Shoya 
1981). This technique has the disadvantages of being expensive, laborious and of 
limited availability. Immunohistochemistry, on the other hand, may be performed in 
any histology laboratory, is less expensive and more suitable for inclusion into routine 
diagnostic services.
In the small animal cases the capability to provide a definitive histological diagnosis 
between cases of thymic lymphosarcoma and thymoma has additional significance in 
terms of the different prognostic implications and treatment options for these two 
tumours.
Thymic lymphosarcoma in either a cat or dog carries a very poor prognosis. In the cat 
the majority of cases will be associated with Feline Leukaemia Virus infection which 
adds the dimension of health risk to other in-contact cats. A proportion of thymic 
lymphosarcomas will respond to cytotoxic chemotherapy should the owner wish to 
pursue such treatment options whereas these therapies are not useful in the treatment 
of thymoma (Bellah, Stiff and Russell 1983).
Thymomas in these species, on the other hand, are commonly, though not exclusively 
benign. Those without an infiltrating growth pattern may be amenable to surgical 
resection and there are reports of these procedures producing a cure. Gores et al.
130
(1994) described a series of twelve cats with thymoma which were treated with 
surgical resection alone. One patient died in the post operative period from persistent 
intrathoracic haemorrhage and one, which had an intercurrent fungal pleuritis, was 
euthanased. The other ten cats showed no sign of recurrence or metastases and most 
were followed up over a substantial period. The authors conclude that in most cats 
with thymomas surgical excision alone can be expected to result in either a cure or a 
long term disease free interval. One cat treated with surgical resection for a thymoma 
which subsequently recurred is described by Martin et al. (1986). Further surgery and 
adjuvant chemotherapy was then undertaken. In this series case 6 was successfully 
treated by surgical resection of the mass.
Successful surgical resection of thymomas in the dog has also been reported (Harris et 
al. 1991, McNeil 1980, Poffenbarger, Klausner and Caywood 1985). In some cases 
post operative medical therapy to control myasthenic signs was necessary 
(Poffenbarger, Klausner and Caywood 1984). In a case reported by Bellah, Stiff and 
Russell (1983) the histological diagnosis on first biopsy of a thoracic mass was thymic 
lymphosarcoma. When the mass failed to respond to standard chemotherapy for this 
disease biopsy was repeated and thymoma diagnosed. This dog was then treated by 
surgical excision of the mass and did well for six months at which time it died 
suffering from anorexia and ascites. Thoracic radiographs were normal but 
laparotomy showed lesions on the spleen and liver. Histopathology was not 
performed.
Transthoracic needle biopsy is a useful technique for the differential diagnosis of 
thymic disease in small animals. It is relatively non-invasive and may be simply
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performed in general practice. As thymic lymphosarcoma is the most common thymic 
malignancy in small animals it is valuable to achieve the diagnosis in the least 
invasive manner as surgical resection is not indicated in the treatment of this disease. 
In the series reported here case 7 was diagnosed by needle biopsy. The core of tissue 
obtained by the practitioner was fixed and submitted for histological and 
immunohistochemical examination. This simple procedure was very effective in 
providing a high quality diagnostic sample. A needle biopsy providing a core of tissue 
to be processed is more informative than aspiration cytology but this method may also 
be used to examine thymic masses.
Rae, Jacobs and Couto (1989) compared cytological preparations and histological 
sections from thirteen canine and feline thymomas. Fine needle aspirate biopsy 
(FNAB) was found to be more useful than impression smears with seven out of nine 
showing recognisable features of thymoma; epithelial-like cells and cytologically 
normal lymphocytes. FNAB of a thymic lymphosarcoma would be expected to yield 
immature/atypical lymphoid cells. The pitfalls of this technique include the relatively 
high likelihood of producing a non-diagnostic sample by aspirating from areas which 
are cystic or where lymphoid cells predominate. It is possible to apply 
immunohistochemical techniques on cytological preparations if required. In this 
situation the technique is more correctly termed immunocytochemistry.
The success of this study in providing confirmation of the possibly difficult 
histological diagnosis of these tumours suggests that immunohistochemistry is a 
valuable adjunct to classical histological examination and diagnosis of thymomas in
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domestic animals and that the technique may be suitable for consideration in the 
diagnostic situation.
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Chapter 3.
Investigating Cytokeratin Subclass Expression Using 
Immunohistochemistry
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3.1.1) Cytokeratin Immunohistochemistry.
In chapter two the use of lineage markers to determine the tissue of origin of thymic 
tumours in domestic animals was assessed. This chapter focuses on the investigation of 
cytokeratin subclass expression in normal canine skin and canine cutaneous neoplasms 
of epithelial origin as a progression from the previous work.
Of the five intermediate filament classes the epithelia-associated cytokeratins are the 
most complex. Moll et al. (1982) catalogued nineteen subsets of human epithelial 
cytokeratins using two-dimensional gel electrophoresis (Table 7). Other subsets also 
exist but these are less well defined. Cytokeratins may be divided into acidic (Type I) 
and neutral to basic (Type II) groups according to their isoelectric point (Table 8). 
Usually two to ten of these subfamilies are present in a particular epithelium.
The particular cytokeratin “finger print” of an epithelium varies according to three main 
factors as follows: (Cooper, Schermer and Sun 1985)
i) epithelial type: simple versus stratified
ii) differentiation type (amongst stratified) e.g. skin, cornea, oesophagus
iii) state of cellular growth: normal versus hyperproliferative
Examples of tissue cytokeratin profiles are shown in table nine. Cytokeratins are 
usually expressed as a pair consisting of one of each type. In these pairs the 
neutra^asic subunit is approximately 8kDa larger than its acid counterpart (Cooper, 
Schermer and Sun 1985). In general, higher molecular weight cytokeratins are present
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in complex stratified epithelia such as skin or oesophagus while lower molecular 
weight cytokeratins are more commonly found in simple epithelia, e.g. hepatocytes or 
glandular acinar cells. Both high and low molecular weight cytokeratins are expressed 
in ductal epithelia, e.g. mammary, bronchogenic, skin adnexal and biliary and 
pancreatic ducts. This is also the case in transitional mucosa and mesothelium. These 
fairly consistent “rules” of cytokeratin expression suggest that the identification of 
specific types of keratin may be of diagnostic value.
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no. mw(kDa) Pi no. mw(kDa) P*
1 68 7.8 11 56 5.3
2 65.5 7.8 12 55 4.9
3 63 7.5 13 54 5.1
4 59 7.3 14 50 5.3
5 58 7.4 15 50 4.9
6 56 7.8 16 48 5.1
7 54 6.0 17 46 5.1
8 52.5 6.1 18 45 5.7
9 64 5.4 19 40 5.2
10 56.5 5.3
Table 7. Cytokeratin subclasses as classified according to Moll et al (1982)
Cvtokeratin Subclasses
Type I Type 11
acidic neutral/basic
9 1
10 2
11 3
12 4
13 5
14 6
15 7
16 8
17
18
19
Table 8. Cytokeratin subclasses grouped according to isoelectric point.
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In practice  there are tw o  m ain  ap p lica tion s for cytokeratin  im m u n oh istoch em istry:
i) it allows an undifferentiated neoplasm to be identified as epithelial in origin
For this purpose a broad spectrum antibody reactive to an epitope conserved among the 
subclasses or a mixture of antibodies which identify different cytokeratins is used.
ii) it can aid histogenic subclassification of tumours (epithelial tumours) by determining 
whether the tumour is derived from simple, ductal or squamous epithelium. In this 
situation antibodies for defined cytokeratin subclasses are used.
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C vtokeratin  Subclass D istribution
epidermis 1 (2 )5  10 11 14 (15 )
oesophagus 4 5 (6 )  13(14,15,16, 17,19)
simple epithelium (e.g. hepatocyte) 8 18
ductal epithelium (e.g. mammary) 7 8  18 19
transitional epithelium (bladder) (5) 7 8 (13) (18) 19
Table 9. Examples o f  human tissue cytokeratin profiles. (Derived from Moll et al 1982)
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3.1.2) Skin Tumours of the Dog
A variety of skin neoplasms arising from the cells which compose or migrate to the skin 
and its associated structures are recognised in the dog (and in other domestic animal 
species). The classification and prognostication of these tumours composes a large part 
of the work of a diagnostic veterinary pathology service.
Although some of the common skin tumours of dogs are classified as “round cell” 
tumours, including mast cell tumours, the most common malignant skin tumour in 
canines (Goldschmidt and Shofer 1992) and histiocytomas - benign growths which 
often regress spontaneously (Taylor, Dorn and Luis 1969), a significant number of 
canine skin growths arise from the local epithelial structures and it is these which are 
examined in this chapter.
The classification of some of these tumours, for example the squamous carcinoma, is 
well established with little discordance between different authors. For other lesions, 
perhaps most notably the benign skin adnexal tumours, there are significant differences 
in the approach to classification between authors. Gross, Walder and Irke (1992) 
espouse a fairly complex system of subdivision for these tumours whilst other 
authorities on veterinary dermatopathology like Jaeger and Wilcox (1994) regard such 
efforts an exercise in semantics.
It is therefore of interest to apply the newer developments in immunohistochemical 
technology to these tumours to assess whether the results assist in determining a 
meaningful classification system based on cutaneous embryology.
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In this study the immunohistochemical examination of cytokeratin subfamilies 
expressed in the skin and associated epithelial neoplasms of the dog is undertaken using 
commercially available anti-cytokeratin antibodies raised against human proteins.
Before commencing this work it was necessary to:
i) review the range of canine cutaneous epithelial tumours to be studied
ii) refer to the patterns of tissue cytokeratin expression noted in investigations of human 
tissue.
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3.1.3) Epithelial Tumours Investigated in This Study
A classification system for neoplasms of the skin of domestic animals was published by 
Weiss and Frese in 1974 under the auspices of the World Health Organisation (WHO). 
They state that "tumours occur more frequently in the skin than any other part of the 
body". The following are the classifications of epithelial skin neoplasms recognised by 
these authors.
WHO Epithelial Skin Tumour Classification
Basal cell tumour (basal cell carcinoma)
Squamous cell carcinoma 
Papilloma i)squamous cell papilloma 
ii)fibropapilloma 
Sebaceous gland tumour i)sebaceous adenoma
ii)sebaceous carcinoma
iii)tumour-like hyperplasia 
Tumour of hepatoid (perianal) glands i)adenoma
ii)carcinoma
iii)tumour-like hyperplasia 
Sweat gland tumour i)papillary syringadenoma
ii)cystadenoma of apocrine sweat glands
iii)spiradenoma
iv)mixed tumour of apocrine sweat glands
v)carcinoma of apocrine sweat glands a)papillary carcinoma
b)tubular carcinoma
c)solid carcinoma
d)signet ring cell carcinoma
Tumour of hair follicle i)trichoepithelioma
ii)necrotizing and calcifying epithelioma 
Intracutaneous comifying epithelioma 
Cysts i)epidermal cyst
ii)dermoid cyst
iii)follicular cyst
iv)cyst with epithelial proliferation
Controversy exists over the classification of basal cell and appendage tumours in 
domestic animals. Many veterinary pathologists broadly follow the classification used
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for human tumours which is similar to the above but recognises different phenotypic 
variants of the basal cell tumour (solid, cystic, ribbon and medusoid) and lists 
pilomatrixoma as a hair follicle tumour (Pulley and Stannard 1990). Some espouse a 
simpler classification which terms most of the histological subdivisions “basal cell 
tumours with follicular (or adnexal) differentiation” (Jaeger and Wilcox 1994) and 
some work to a complex and very comprehensive system of subclassification as 
suggested by Walder and Gross (1992).
Some of the major epithelial skin tumours of dogs are considered in detail in this study: 
Tumour types were selected for inclusion in this study on the basis of being relatively 
prevalent and serving as examples of different pathways of differentiation.
Squamous Cell Carcinoma of the Skin
Squamous cell carcinoma is a malignant tumour arising from the squamous epithelium 
of the epidermis or mucosal surfaces. This tumour affects all domestic species but is 
most common in the dog, cat, horse and cow. It has been reported to be the second most 
common malignant neoplasm of the skin in dogs after mast cell tumour (Walder and 
Gross, 1992). A large scale survey undertaken by Goldschmidt and Shofer (1992) 
placed squamous cell carcinoma at 5% of all epithelially-derived neoplasms in dogs, 
approximately 1.75% of all canine skin tumours.
In the dog the most common sites of origin include the oral cavity, the skin on the legs, 
trunk, scrotum, lips and the nail bed epithelium. Goldschmidt and Shofer (1992) 
suggest that Bloodhounds, Bassett Hounds and Standard Poodles are at increased risk
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of developing squamous cell carcinomas and Madewell et al. (1982) reported that such 
tumours originating on the digits developed more frequently in black Labrador 
Retrievers and black Standard Poodles.
There is a general tendency in all species for squamous cell carcinoma to develop in 
unpigmented areas of skin, especially where the overlying hair coat is short or sparse. 
Sun exposure is a known risk factor as UVB radiation induces DNA damage in 
keratinocytes, and squamous carcinomas may be preceded by actinic keratosis (Hargis 
and Thomassen 1979, Hargis, Thomassen and Phemister 1977). In dogs with a history 
of sun-bathing behaviour, especially in sunny climates, the head, ventral abdomen and 
perineum are predilection sites for tumour development. Thermal injury of the skin may 
also predispose to the development of this tumour.
Squamous cell carcinomas are locally invasive but are usually slow to metastasise. An 
exception to this generalisation is squamous cell carcinoma of the digit, which despite 
its often well differentiated histological appearance tends to be highly invasive, 
osteolytic and more commonly metastatic. Metastasis to the local lymph nodes and 
lungs from tumours of the digit has been reported in up to 40% of cases in comparison 
with 5% for squamous carcinomas overall (Jaeger and Wilcox 1994).
Grossly, squamous carcinomas may produce papilliform growths which tend towards 
ulceration of the surface, or more commonly, be erosive and produce ulcers which 
become deeper and more severe with time (Pulley and Stannard 1990).
Histologically the tumours are composed of irregular masses, nests or cords of 
proliferating epidermal cells which invade the dermis and subcutis (see fig. 31). In
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general the cells have large vesicular nuclei with prominent nucleoli and a moderate to 
high mitotic rate. Aberrant mitotic figures may be seen. The cytoplasm is eosinophilic 
and abundant. The growths are often fairly well differentiated with a reasonably orderly 
progression from cells resembling the basal layer of epithelium at the periphery of nests 
or masses to large, keratinising cells with eosinophilic cytoplasm and pyknotic nuclei at 
the centres. The amount of keratin produced depends on the degree of differentiation, in 
well differentiated tumours numerous keratin “pearls”, composed of concentric layers 
of keratinising cells and keratin, are seen. Well differentiated squamous cell carcinomas 
also show prominent intercellular bridges, an artefactual effect produced by the 
stretching of desmosomes between the cells which shrink during fixation. There is a 
variable amount of stromal collagen production and inflammatory cells may be present.
Poorly differentiated histological variants are less common but do occur. In these 
growths the epithelial structures tend to be smaller and often include cords of cells with 
a highly invasive growth pattern. There is often less stromal collagen and the cells are 
hyperchromatic with amphophilic cytoplasm and no keratin pearl formation, although 
individual dyskeratotic cells may be seen. The mitotic rate is typically high and there is 
nuclear and mitotic atypia.
Papillomas
Papillomas are benign epithelial neoplasms and there are various manifestations of 
these skin growths. Squamous papillomas may be induced in dogs by infection by 
canine papilloma virus, a member of the papovaviridae family of double stranded DNA 
viruses. The reported incidence of such cases is between 1 and 2.5% of all canine skin
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tumours (Walder and Gross 1992b). These lesions are typically exophytic and sized a 
few millimetres to (rarely) a few centimetres in diameter. The predilection sites for viral 
papillomas are the face and the oral cavity and spontaneous regression over several 
weeks to months is usual. Multiple oral papillomas are seen in cases of canine oral 
papillomatosis. This infectious condition is seen in young or immunosuppressed 
animals and although spontaneous regression occurs in most cases, malignant 
transformation to carcinoma has been recorded. Squamous papillomas with no evidence 
of viral involvement may also occur. These are often smaller, usually l-5mm in 
diameter and occur most commonly on the face, eyelids, conjunctiva and footpads.
Histologically, typical viral papillomas are composed of finger-like projections of 
cytologically mature squamous epithelium. The epithelial projections are heavily 
keratinised and an inflammatory infiltrate is common in the stroma of the papillae. 
Viral cytopathic effects are manifest by koilocytosis and the formation of large 
keratohyalin granules. Basophilic intranuclear inclusions may be identified at the 
junction of keratinised and non-keratinised epithelium. Ultrastructural studies have 
demonstrated aggregations of viral particles in the nucleoplasm of cells in the stratum 
granulosum (Watrach 1969). Non-viral squamous papillomas are similar histologically 
but the degree of epithelial hyperplasia and hyperkeratosis is usually less as is the 
inflammatory infiltrate. Specific viral changes are absent (Figure 35).
Fibropapillomas are lesions where a core of excess fibrous tissue is covered by 
papillated squamous epithelium resembling that found in a squamous papilloma.
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Basal Cell Tumour and Appendage Tumours
This group of tumours are important in the dog and cat and rare in other domestic 
species. The basal cell tumour is a distinct undifferentiated epithelial neoplasm of the 
skin. The basal cell characteristic of this tumour is not synonymous with the basal cell 
of the epidermis which is well differentiated and possesses intercellular bridges. It is a 
more primitive pluripotential cell, analogous to the primary epithelial germ cell and 
possesses no intercellular bridges (Pulley and Stannard 1990).
A spectrum of basal cell and appendage tumours exist from undifferentiated basal cell 
tumours to those which resemble fully formed but enlarged sebaceous glands or 
rudimentary hair follicles. Apocrine sweat glands also arise from the primary epithelial 
germ cells but tumours of this type do not exhibit the same spectrum of differentiation 
and are usually divisible into adenomas and adenocarcinomas.
Basal Cell Tumours
Basal cell tumours are composed almost entirely of undifferentiated basal cells and lack 
differentiation towards follicles, sebaceous structures, apocrine glands or squamous 
cells. Synonymous terms used for this tumour include basaloid tumour, basal cell 
epithelioma, basalioma and basal cell carcinoma. The aetiology of this neoplasm is 
unknown.
In two 1950s surveys of skin tumours of the dog basal cell tumours have been found to 
feature at 10% and 5% (Head, 1953 and Cotchin, 1954). A more recently published 
survey of biopsy specimens submitted to the University of Pennsylvania counted basal
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cell tumours at 11% of epithelially derived skin neoplasms in the dog, around 3.8% of 
all canine skin tumours received (Goldschmidt and Shofer 1992). A survey of feline 
basal cell tumours found that they comprised 11-28% of feline skin tumours (Diters and 
Walsh 1984).
Grossly, basal cell tumours are usually solitary dermal or subcutaneous masses ranging 
in size from 0.5-10cm. The masses are firm, discrete and freely moveable over 
underlying tissues. Ulceration of the overlying epithelium is common and secondary 
infection may be a feature of ulcerated lesions. The skin of the head and neck is most 
commonly affected.
Histologically the cells of basal cell tumours have hyperchromatic oval nuclei and scant 
cytoplasm. Some tumours may contain spindle-shaped cells with more elongated 
nuclei. The cells are uniform in size and shape and are usually quite small with poorly 
defined cytoplasmic outlines. Melanin pigment may be present within the basal cells 
themselves and in scattered melanocytes within the tumour, especially in feline 
tumours, and the mitotic rate may be quite high. A fibrous stroma of variable extent 
may subdivide and surround the tumour. The tumours may be subclassified according 
to their histological pattern into solid, cystic, adenoid (as in Figure 38) and medusoid 
variants, but this approach may be unsatisfactory as the majority of tumours are 
composed of more than one pattern. No prognostic significance is attached to the 
various histological subdivisions.
Basal cell tumours in the dog carry an excellent prognosis. Local excision is curative, 
with adequate margins the tumours do not recur at the surgical site and metastasis has 
not been recorded.
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T richoepithelioma
Trichoepitheliomas are uncommon, benign skin tumours recognised in dogs and cats. 
These are epithelial growths which are capable of differentiating towards all three 
segments of the hair follicle therefore variable histological appearances are seen both 
between and within tumour masses. In a study by Bevier and Goldsmidt (1981), 
trichoepitheliomas were recorded at 1-3% of all canine skin tumours. In the cat 
trichoepitheliomas account for 1.5-4% of skin tumours (Theilen and Madewell 1987).
Grossly, trichoepitheliomas are solitary round to oval dermal masses usually less than 
two centimetres in diameter, although larger growths are possible. The skin overlying 
the mass is partially or completely alopecic and ulceration is common, especially in 
larger lesions. The dorsal trunk is a predilection site. Most cases occur in dogs aged five 
years or more. As a breed, the Bassett Hound is predisposed to developing multiple 
trichoepitheliomas (Goldschmidt and Shofer 1992).
Histologically, trichoepitheliomas are well circumscribed but unencapsulated dermal 
nodules composed of a mix of budding epithelial islands of basaloid (small, basophilic 
undifferentiated) cells which resemble primitive follicular bulbs, having scant pale 
cytoplasm and uniform ovoid nuclei and cystic structures of varying size which may be 
lined by similar cells and show extensive matrical keratinisation and some shadow cell 
formation (Figure 43). A hyaline basal lamina resembling the hyaline sheath of the 
catagen hair follicle may support the outer layer of cells The cysts may alternatively be 
lined by squamous epithelium resembling the follicular infundibulum or isthmus or 
they may have a combined appearance. The tumour may be contiguous with overlying
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epithelium and the basaloid and shadow cells may be pigmented. The surrounding 
stroma is relatively acellular.
Rare cases of invasive trichoepithelioma where the growth extends into the subcutis 
and malignant variants with a similar histological appearance and evidence of 
lymphatic spread or node involvement are recorded.
Pilomatrixoma (pilomatricoma)
Pilomatrixomas are uncommon benign neoplasms recognised in dogs which arise from 
the germinal cells of the follicle matrix. Weiss and Frese (1974) quote the incidence of 
pilomatrixomas in dogs as 3% of all skin tumours.
Grossly, pilomatrixomas are solitary, well circumscribed masses typically two to ten 
centimetres in diameter which may be multinodular. Their consistency ranges from firm 
to possibly gritty or bony to the extent that sectioning is very difficult. The masses are 
usually dome-shaped or plaque like, freely moveable over deep tissues with atrophy and 
alopecia of the overlying epithelium. The neck, back and tail are predilection sites. The 
commonest age range for presentation with this tumour is five to ten years. In terms of 
breed disposition the Kerry Blue is greatly over-represented as are Bedlington Terriers 
and Schnauzers. It is suggested that in such breeds which have a continually growing 
haircoat there are greater numbers of active anagen hair follicles and due to this an 
increased susceptibility to pilomatrixomas.
Histologically the masses are well circumscribed and dermal to subcutaneous in 
location. The growth is composed of single or multiple cysts lined by basophilic
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basaloid keratinocytes resembling the matrix of the hair bulb with their large, 
hyperchromatic ovoid nuclei and scant cytoplasm (Figure 47) . These cells may show 
fairly numerous mitoses. There may be regions of squamous epithelium formation with 
or without a stratum granulosum and foci of differentiation towards inner root sheath 
with shadow cell formation. In the centre of the tumour nodules, particularly in long­
standing lesions, there is commonly extensive differentiation to shadow cells and 
accumulation of keratinised debris with giant cell formation which may progress to 
calcification or osseous metaplasia. The cysts are set in a moderately cellular stroma of 
collagen and mucin. Melanin pigment may be seen in tumour cells or in stromal 
melanophages. Rupture of the cysts leads to granuloma formation.
In their book "Skin Tumours of the Dog and Cat" (Pergamon Press, 1992) Goldsmidt 
and Shofer present one of the most comprehensive surveys of cutaneous neoplasia in 
these species using data collected from the submissions to the Pathology service at the 
University of Pennsylvania Veterinary School. The figures supplied in this large scale 
survey are expressed divided into epithelial and mesenchymal classes but when they are 
converted and expressed as percentages of skin tumour totals (this is also the method 
used in Table 10 in Results) the figures are as follows: Basal cell tumours add up to 
3.9% of all canine skin neoplasms examined, squamous cell carcinomas account for 
1.8%, papillomas composed less than 0.35% of this survey whilst trichoepitheliomas 
and pilomatrixomas numbered 4.2% and 1% respectively.
In an earlier survey, Nielsen and Cole (1960) examined 7489 skin lesions in dogs and 
found 153 epithelial neoplasms, excluding mammary and perianal gland tumours (2% 
of the surveyed material). The numbers of non-epithelial neoplasms were not recorded
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so it is not possible to give figures for prevalence of individual tumour types against 
total skin tumour numbers. 33 basal cell tumours (21.5% of epithelial neoplasms), 31 
squamous carcinomas (20.3%), 7 trichoepitheliomas (4.5%), 9 squamous papillomas 
(5.9%) and 5 calcifying epitheliomas, synonymous with pilomatrixomas (3.4%) were 
identified.
In a 1970 survey Brody found the skin to be the commonest site for neoplasms of the 
dog, representing 35.6% of 2917 neoplasms. Of these 984 skin tumours, 445, 
(approximately 45%) were of epithelial origin. In this survey 205 "adnexal tumours" 
were not separated into basal, follicular or glandular variants but it was recorded that 
the Kerry Blue breed was over-represented in the follicular tumour group. In agreement 
with the findings of Liu and Hohn (1968) the digit was found to be an important site for 
squamous carcinoma with these lesions being associated with increased incidence of 
metastases.
Bostock (1986) states that ten tumour types account for 80% of all canine cutaneous 
neoplasms. These are listed as mastocytoma (mast cell tumour), hepatoid adenoma, 
lipoma, sebaceous adenoma, fibrosarcoma, melanoma, histiocytoma, squamous cell 
carcinoma, haemangiopericytoma and basal cell tumour. The total frequency of canine 
skin tumours is reported to be approximately 450 new cases per year per 100,000 dogs.
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3.2.1) Review of the Epithelial Structures of the Skin
The epidermis is a stratified squamous epithelium that forms the protective covering of 
the skin. In this membrane the more superficial cells are flattened while the deeper 
layers vary from cuboidal to columnar. Other examples of stratified squamous 
epithelium are found in the cornea, the mucous membrane of the oral cavity and the 
oesophagus. In contrast to these other epithelia the surface of the skin is dry and the 
superficial cells transform to provide a tough, protective, non-living layer of keratin. 
Associated with the epidermis are the epithelial structures of the hair follicles and 
adnexa.
The epidermis is renewed by a balanced process of growth (proliferation) and 
differentiation and is organised into layers reflecting stages in these dynamic processes. 
In most areas of mammalian skin the epidermis consists of four layers:
stratum basale /  stratum germinativum (basal cell layer) 
stratum spinosum (prickle cell layer) 
stratum granulosum (granular cell layer) 
stratum corneum (homy layer)
In the footpad and nasal planum skin of the dog and in the palms and soles of humans a 
fifth layer, the stratum lucidum (clear layer) exists beneath the stratum corneum.
In transit from the basal layer to the dead squamous layer an epidermal cell will 
undergo a series of morphological and biochemical changes. Various morphological 
and biochemical features characterise the stages of epidermal growth and 
differentiation.
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The stratum basale is composed of a single layer of cells resting on the basement 
membrane. Within this layer there is some morphologic and functional heterogeneity as 
some cells function primarily in anchoring the epidermis whilst others act as 
proliferating stem cells (Goldsmith 1991). Cells of the stratum basale possess 
desmosomes - membrane junctions which link them in a three dimensional manner. 
Melanocytes (pigment producing cells) are also located at this level. Only this inner, 
basal cell layer of the epidermis has the capacity for DNA synthesis and mitosis 
(Weinstein and Van Scott 1965).
Human epidermal basal cells have in their cytoskeleton a dispersed but extensive 
network of cytokeratin filaments composed of equal amounts of CK5 (58kDa) and 
CK14 (50kDa) (Nelson and Sun 1983). These cytokeratin subfamilies are the hallmarks 
of a stratified epithelium.
Immediately above the basal layer is the spinous layer {stratum spinosum). In haired 
areas of canine skin this layer tends to be one to two cells in thickness. In histological 
sections, intercellular bridges (prickles/spines) appear to connect the cells of this layer. 
As in squamous cell carcinoma this distinctive appearance is a processing artefact. 
These cells are post-mitotic but metabolically active (Fuchs 1990).
As cells enter the spinous layer they increase steadily in size and in human studies have 
been shown to produce two additional cytokeratins, CK1 (67kDa) and CK10 (56.5kDa) 
which aggregate into thin bundles or tonofilaments (Eichner, Sun and Aebi 1986). 
These are produced due to changes in the transcription of specific mRNAs and their 
production represents a commitment to terminal differentiation. Spinous cells also
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synthesise glutamine and lysine rich envelope proteins, such as involucrin, which are 
deposited on the inner plasma membrane of each cell (Rice and Green 1979).
The stratum granulosum is variable in canine haired skin and when present is one to 
two cells thick. In non-haired areas and at follicular infundibula this layer can be four 
to eight cells thick. The “granules” are insoluble keratohyalin aggregates within the 
cells.
As epidermal cells enter the granular layer (stratum granulosum) they stop synthesising 
cytokeratins and envelope proteins but produce filaggrin and loricrin. Filaggrin has at 
least two functions, it aggregates, packs and aligns keratin filaments and produces the 
matrix between the keratin filaments in the comeocyte and it also acts as a source of 
free amino acids which are important for maintaining normal hydration of the stratum 
corneum (Scott, Miller and Griffin 1995). Loricrin is a protein known to be a major 
component of the comified covering of the skin (Mehrel et al. 1990).
Subsequently the cells become permeable and an influx of calcium activates the 
enzyme epidermal transglutaminase which catalyses the formation of bonds which 
cross-link the envelope proteins (Rice and Green 1979). Other, lytic enzymes are 
released and the metabolic activity in the cells ceases, producing squames - flattened, 
anuclear, eosinophilic cells made up of macrofibrils of keratin. The squames comprise 
the comified layer (stratum corneum). This superficial layer of terminally differentiated 
keratinocytes is sealed together with lipids and constitutes an impermeable barrier 
which prevents entry of micro-organisms and loss of body fluids.
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In epidermal disease states associated with hyperproliferation the expression of the 
differentiation-associated cytokeratins 1 and 10 is downregulated and a different set of 
proteins, CK6 (56kDa) and CK16 (48kDa), is induced. These are similarly located in 
the suprabasal epidermis (Koplan and Fuchs 1989). It is important to note that in 
addition to being expressed in epidermis under conditions of hyperproliferative “stress” 
that cytokeratins 6 and 16 together with 17 (46kDa) are normally expressed in hair 
follicles (Mclean and Lane 1995).
The balance between differentiation and proliferation is important for the generation of 
normal epidermis. In the living animal many factors interact and the functions of some 
of these have been elucidated using cell culture techniques.
It is known that calcium is a prerequisite for several processes in differentiation 
including stratification, desmosome assembly and activation of epithelial 
transglutaminase (Hennings et al. 1980, Watt, Mattey and Garrod 1984).
The retinoids, derived from retinoic acid (a vitamin A analogue) are an important class 
of morphogenic regulators in some systems. The effect of these compounds on 
differentiation depends on their interaction with cytoplasmic retinoic acid binding 
protein in the target cells (Graham 1992). Retinoids reduce the development of terminal 
differentiation in stratified squamous epithelium (Fuchs and Green 1981) and excess 
retinoids have been shown to reduce the expression of CK1, CK10, CK6, CK16, 
comified envelope production and filaggrin (Fuchs 1990).
Physical factors are also important in directing normal epithelial (epidermal) 
development - cultures mimicking the natural situation where epidermal cells are
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exposed to air and receive nutrition via diffusion show enhanced differentiation 
(Asselineau et al. 1986). Epithelial growth factor (EGF) stimulates keratinocyte growth 
as do TGFa, IL-6, IL la  and various fibroblast factors.
To commit to terminal differentiation a cell must leave the cell cycle. TGFp inhibits 
DNA synthesis and cell division in basal cells, however it is expressed in greater 
amounts suprabasally where it may be important in maintaining growth arrest in the 
differentiating layers. At high levels TGFp inhibits rather than promotes the synthesis 
of CK1 and CK10 and filaggrin but increases the synthesis of CK6 and CK16. The 
effects of TGFp seem to differ at different stages of epidermal differentiation (Choi and 
Fuchs 1990).
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3.3.1) Materials and Methods
The computerised database of the records of the external biopsy service operated by the 
Canine Infectious Disease Research Unit (CIDRU) within the Department of Pathology 
was reviewed for cases of the previously listed skin tumours which were selected with 
reference to their relative prevalence. Conventionally stained sections were examined 
and suitable cases selected for inclusion in the study. Normal canine skin and liver were 
used as control tissues.
In this study examples of each of the previously described canine skin growths; six 
squamous carcinomas, five papillomas, seven basal cell tumours, five 
trichoepitheliomas and five pilomatrixomas plus the controls were examined with four 
commercially available anti-human cytokeratin antibodies. In addition, a single 
example of each tumour type plus the control tissues was stained by the pan-cytokeratin 
marker routinely used in the laboratory. These antibodies were all mouse anti-human 
monoclonals, three purchased from Novocastra Laboratories (Newcastle-upon-Tyne, 
England):
antibody to cytokeratin (CK) 14 NCL-LL002
antibody to cytokeratin (CK) 16 NCL-CK16
antibody to cytokeratin (CK) 18 NCL-CK18
and one purchased from Dako (Glostrup, Denmark): 
antibody to cytokeratin (CK) 10 DE-K10
The pan-cytokeratin in routine use in the laboratory is also supplied by Dako (Glostrup, 
Denmark):
recognises cytokeratin sub-families 5,6,8,17,(19) MNF116
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Blocks of the tumours of interest were selected from the Department of Pathology 
archives and sections from these were cut at approximately 5 pm onto coated slides 
(APES: 3-amino-propyltriethoxysilane) to promote adhesion. These sections were dried 
overnight at 37°C. For each test section a corresponding negative control section was 
also cut and processed in parallel.
After dewaxing and rehydrating as described in Chapter 1 the sections were subjected 
to a standard protocol according to the manufacturers’ recommendations. A 
commercially available ABC detection kit (Vectastain Elite anti-mouse IgG, Vector 
Laboratories, Burlinghame, CA, USA.) was used.
For the CK 14, 16 and 18 antibodies this involved a high temperature antigen 
unmasking step. In this procedure 0.01M tri-sodium citrate buffer at pH 6.0 was 
brought to the boil in a pressure cooker without locking the lid. The sections were then 
immersed in the boiling solution and the lid locked in place. Heating was continued and 
after approximately four minutes the pressure indicator valve rose and the sections were 
incubated at this high pressure for one minute. The pressure cooker was then cooled in 
water and the sections were removed once the pressure had fallen. At this point the 
sections were placed in distilled water then in tris buffered saline (TBS).
Enzymatic pre-treatment using 0.1% trypsin with 0.1% calcium chloride in tris-buffered 
saline for thirty minutes at room temperature was employed to unmask the desired 
antigenic sites before incubation with MNF116.
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In the case of the CK10 antibody neither high temperature processing nor enzymatic 
digestion is necessary and the sections were taken from rehydration, through rinses in 
tris buffered saline (TBS) to the next stage.
In all cases the next stage was quenching of endogenous peroxidase activity for which 
the sections were immersed in 1.5% hydrogen peroxide in methanol for ten minutes. 
Subsequently the sections were rinsed in distilled water for five minutes then in two 
changes of TBS for five minutes each.
After this the slides were placed in a humidity chamber and the tissue sections ringed 
using a PAP pen as described in Chapter 2. At this stage all the sections were covered 
with buffered pre-immune serum from the same species in which the secondary 
antibody was raised. In this case the serum was derived from horse. After thirty minutes 
incubation the test sections had the excess pre-immune serum blotted off and the 
primary antibody (see above) applied. Sixty minutes incubation at room temperature in 
the humidity chamber followed. During this time the corresponding negative controls 
continued to be incubated with the pre-immune serum.
After the incubation time the sections were rinsed for five minutes in TBS twice, the 
biotinylated secondary antibody was applied and the sections incubated for thirty 
minutes.
A further five minute rinse was followed by thirty minutes incubation in an avidin- 
biotin-peroxidase complex, a similar rinse and incubation with a peroxidase substrate 
solution. In this case AEC (3 amino-9 ethylcarbazole) was the substrate used. An
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incubation time of fifteen to twenty minutes was found to produce good staining 
intensity.
After rinsing in tap water the sections were counterstained with fresh Meyer’s 
haematoxylin with a twenty second immersion in the stain producing adequate 
counterstaining. Because AEC is soluble in the traditional dehydrating agents (see 
Chapter 1), aqueous mounting is required. For this purpose Supermount™ (Biogenex, 
San Ramon, CA, USA) was applied over the tissue section and allowed to dry 
overnight. To protect the sections they were subsequently mounted and allowed to dry 
before examination.
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3.4.1) Results
i) Archival Survey Results
A review of the database of the external biopsy service in the Department of Pathology 
at Glasgow University Veterinary School over the ten year period 1986-1996 produced 
the following results. The five most prevalent types of cutaneous epithelial tumours 
were chosen for inclusion in this study. The records for cases of skin tumours of 
epithelial origin showed basal cell tumours to be the most common by a large margin. 
The second most common epithelial tumour and by far the most common malignant 
epithelial tumour was the squamous carcinoma. These tumours provide examples of 
different biological behaviour patterns and differentiation pathways. The results of the 
survey of the archival records are summarised in Table 10 below.
Basal cell tumour 281 6.5%
Squamous cell carcinoma 59 1.4%
Papilloma 52 1.2%
Pilomatrixoma 100 2.3%
T richoepithelioma 94 2.2%
Sebaceous epithelioma 89 2%
Intracutaneous epithelioma 73 1.7%
Sebaceous adenoma 85 1.9%
T richofolliculoma 15 0.3%
Hamartoma 53 1.2%
Fibroadnexal dysplasia 4 <0.1%
Papillary cystadenoma 4 <0.1%
Papillary adenoma 2 <0.1%
Table 10. Canine skin tumours of epithelial origin diagnosed in the external biopsy 
service. The percentages relate to the total number o f skin tumours o f  all types.
162
ii) Cytokeratin intermediate filament expression in canine skin
After staining by the described method the sections were reviewed and the patterns of 
expression of each particular cytokeratin for normal canine skin, liver and each tumour 
under investigation were noted.
Normal canine skin
Figure 26 diagramatically illustrates the cell layers of normal canine epidermis and the 
cytokeratin expression of this tissue, whilst Figure 27 shows a conventionally stained 
section of normal canine skin.
CK14 expression was universal in the basal layers of the surface epithelium and in all 
layers of the hair follicle epithelium. In the thin epidermis it was sometimes difficult to 
discern separate layers in the immunostained sections but some suprabasal CK14 
positivity, which appeared to be of a lesser intensity, was also apparent. The cells of the 
adnexal glands were positive and the superficial keratin crust was unstained (Figure 
28).
A faint positivity to CK18 was detected in some apocrine gland cells but staining in 
these cells was also detected in the negative control sections so this finding was 
interpreted as non-specific binding.
Positive staining with CK10 antibody (Figure 29) was seen in suprabasal, but not basal, 
surface epithelium, in the follicular infundibula and part of the inner root sheath. The 
“basal” layer of the outer root sheath, the apocrine and the sebaceous gland epithelia 
were negative.
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Figure 26. Diagramatic representation o f  canine epithelium indicating position o f  
cytokeratin staining.
iCKlO
CK14
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Figure 27 Normal canine skin. H&E (medium power)
Figure 28 Normal canine skin. Note widespread staining in epidermis, especially 
in basal layer, in hair follicles and adnexal epithelium CK14 (medium power)
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The follicular epithelium save for the outer layer of the outer root sheath and the hair 
bulb itself was CK16 positive. Some cells of the surface epithelium and the sebaceous 
glands were faintly positive for CK16.
The pan-cytokeratin antibody produced staining in all layers of the epidermis, the walls 
of the hair follicles, the apocrine glands and the basal cells of the sebaceous glands. Part 
of the hair bulb was consistently negative (Figure 30).
Liver
A section of liver was included as an example of simple epithelium. No positivity was 
demonstrated for CK10, CK14 or CK16. Staining with antibody to CK18 produced 
faint positivity but the staining definition was not good. With the pan-cytokeratin the 
strongest staining was in the bile duct epithelium and there was faint staining in the 
hepatocytes.
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Figure 29. Normal canine skin. Note staining in suprabasal epidermis and inner 
root sheath CK10 (medium power)
Figure 30. Normal canine skin. All epithelial cells except some in the hair bulb 
are stained. Broad-spectrum cytokeratin (medium power)
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iii)  C u ta n e o u s  e p ith e lia l tu m o u r s
Although in the tumours slight variations in antibody results were observed within each 
lesion type broadly group specific reaction patterns could be discerned. These are noted 
in Table 11 and described in detail in the text which follows it.
UBSEM
squamous carcinoma +(-) +++ ++ -
papilloma -(+) +++ ++ -
basal cell tumour - +++ + -
trichoepithelioma ++(-) +++ ++ -
pilomatrixoma - ++(+) ++ -
Table 11. Record o f  staining results for epithelial tumours. 
- = no staining in any tumour case examined 
(-) = no staining in some o f  the tumour cases examined 
(+) = limited staining in some o f  the cases 
+ = small numbers o f  positive cells 
++ = large numbers o f  positive cells 
+++ =  majority o f  epithelial cells positive
Squamous carcinoma
An example o f  a conventionally stained canine squamous carcinoma is shown in Figure
31.
In the squamous carcinoma cases there was staining o f  all the epithelial cells o f  the 
tumours with CK14. This was the case for all tumours examined although staining 
intensity varied from section to section. This staining was cytoplasmic and granular in 
nature. One example o f  a squamous cell carcinoma stained for CK14 is shown in Figure
32.
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Figure 3 1. Canine squamous cell carcinoma Nests and cords o f  malignant 
epithelial cells invade through the dermis H&E (medium power)
Figure 32. Canine squamous cell carcinoma All the malignant epithelial cells 
are strongly stained CK14 (medium power)
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Figure 33. Canine squamous cell carcinoma This tumour is negative for the 
ditYerentiation associated CK10 CK10 (medium power)
Figure 34 Canine squamous cell carcinoma. Strong and widespread positivity 
for CK16. CK16 (medium power)
Looking at the CK10 expression in the squamous carcinomas a slightly more variable 
pattern emerged. In two tumours in this study individual cells within keratin pearl 
formations (the most differentiated areas of the tumour) stained positive as did some 
spinous cells which were faintly stained. In the rest of the selected tumours no cells 
were positive for this marker of differentiation (Figure 33).
With the anti-CK16 antibody tumour cells with a basaloid appearance, where they 
appeared, were negative whereas there was widespread staining of cells resembling 
stratum spinosum in five sections. One of these is shown in Figure 34. In one case only 
individual cells or groups of cells were stained with rather poor intensity.
In the squamous carcinoma stained with the pan-cytokeratin the obviously epithelial 
"islands" of neoplastic cells were strongly positive. Some of the surrounding spindle 
shaped cells were weakly positive whilst some were clearly negative.
Papilloma
One example of a canine papilloma stained with haematoxylin and eosin is shown in 
Figure 35.
In the papillomas examined CK14 produced positive staining in all the epithelial cells. 
This staining varied in intensity between sections.
CK18 results were uniformly negative in this class of tumour.
A variable set of results for the anti-CKlO antibody was obtained in the papillomas. 
One was completely negative, two had individual positive cells and two showed 
widespread but weak positivity. In all cases the adjacent normal epithelial was
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Figure 35 Canine papilloma. H&E (low power)
t
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Figure 36 Canine papilloma. The papilloma is negative whilst the adjacent, 
rather hyperplastic, epithelium is positive CK10 (medium power)
1 7 2
Figure 37. Canine papilloma Widespread staining in cells with spinous 
morphology. CK16 (medium power)
Figure 38 Canine basal cell tumour showing a mostly adenoid pattern and 
prominent fibrous stroma H&E (medium power)
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noticeably more stained with this antibody than was the papilloma. This is effectively 
illustrated in Figure 36.
The results with CK16 were largely positive in the suprabasal areas of the papillomas. 
Staining was restricted to cells with spinous layer morphology (Figure 37).
An inverted papilloma was stained using the pan-cytokeratin antibody and the cells 
resembling stratum spinosum were all strongly positive whilst the cores of the filliform 
growths and the parakeratotic crust were negative.
Basal cell tumour
Figure 38 shows one example of a canine basal cell tumour with a mostly adenoid 
pattern.
In four of the basal cell tumours a population of negative cells was present admixed 
with the positive ones (Figure 39) but in the others all the tumour cells were positive for 
CK14 (Figure 40). In no case of basal cell tumour was any positivity for CK18 
detected.
Interestingly, no basal cell tumours had any positive staining when reacted with CK10 
antibodies (Figure 41).
With the anti-CK16 antibody three basal cell tumours had low intensity staining in 
many cells and four had only small numbers of positive cells. Figure 42 shows a basal 
cell tumour where many cells are stained with a fairly low intensity. 
All the epithelial cells of the basal cell tumour tested were positive with the pan- 
cytokeratin marker.
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Figure 39. Canine basal cell tumour A population o f  negative cells accompany 
the positive cells in this adenoid basal cell variant CK14 (medium power)
Figure 40. Canine basal cell tumour. In the case o f  this solid basal cell tumour 
all the cells are positive CK14 (medium power)
CK14 (medium power)
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Figure 41. Canine Basal Cell Tumour All these growths were negative for CK10 
C K 10 (medium power)
Figure 42. Canine Basal Cell Tumour. Many cells are stained with low intensity. 
CK 16 (medium power)
T richoepithelioma
An example of a typical canine trichoepithelioma stained with haematoxylin and eosin 
is shown in Figure 43.
Epithelial staining for CK14 was widespread in these growths with a consistent pattern 
in all sections where a few cells inside whorl formations and a few knots of cells were 
left unstained (Figure 44).
No positive staining was detected in trichoepithelioma sections stained with CK18.
The results obtained by staining these tumours with CK10 were rather variable. Three 
had occasional cell positivity in the walls of the larger keratinizing cystic elements and 
two were negative. One negative example is pictured in Figure 45.
With the anti-CK16 antibody there was a consistent pattern of strong focal staining in 
the whorls and follicular elements (Figure 46).
With the pan-cytokeratin all the epithelial structures of the trichoepithelioma examined 
were positively stained.
Pilomatrixoma
Figure 47 shows a conventionally stained canine pilomatrixoma.
In these tumours the epithelial lining of the cystic structures was wholly positive to 
CK14 in some sections and patchily positive in others (Figure 48). The staining was of 
variable intensity.
No epithelial structures of these tumours stained with antibody to CK18.
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Figure 43 Canine Trichoepitheliom a H& E (low  pow er)
. /  ■ ■. -
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k V ®  A  *
Figure 44 Canine Trichoepithelioma. Widespread positivity o f  all epithelial 
elements with only small groups o f  cells unstained CK14 (low power)
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Figure 45. Canine Trichoepithelioma No positive staining was observed in 
this tumour CK 10 (low power)
Figure 46 Canine Trichoepithelioma All these tumours had strong focal 
staining in the walls o f  the follicular elements CK16 (medium power)
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The epithelial walls of the tumours were CK10 negative in all pilomatrixomas tested 
(Figure 49).
The inner (luminal) epithelial layers of the follicular/cystic structures showed positivity 
to CK16. Areas of squamous differentiation also tended to be CK16 positive. Focal 
strong positivity is illustrated in Figure 50.
With pan-cytokeratin staining many epithelial structures were wholly positive. In some 
of the larger cystic areas the staining was variable with negative areas.
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Figure 47 Canine Pilomatrixoma Section shows a single large dermal cystic 
element with a well circumscribed epithelial wall H&E (low power)
Figure 48. Canine Pilomatrixoma Section shows part o f  the epithelial wall 
which is patchily stained CK14 (medium power)
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Figure 49. Canine Pilomatrixoma. The growth shown had multiple cystic
elements, all unstained No CK10 positivity was Found in any pilomatrixoma
tested CK10 (medium power)
Figure 50. Canine Pilomatrixoma Focal areas o f  strong positivity are seen. 
CK16 (medium power)
3.5.1) Discussion
The aim of this work was to investigate whether commercially available anti-human 
antibodies could be used to determine the cytokeratin profiles of canine skin and 
cutaneous epithelial neoplasms and if so to assess whether consistent profiles of protein 
expression existed within tumour types.
Of the tumours examined in this study the squamous carcinoma has the most serious 
implications for the animal as it is a malignant tumour and the papilloma is its benign 
counterpart. The basal cell tumour falls into a separate category of non-metastatic but 
locally aggressive growths and the trichoepitheliomas and pilomatrixomas are different 
examples of benign adnexal skin tumours. The profile of each of these was considered 
with reference to the staining pattern of normal canine skin.
With CK14 normal skin stained positive in the basal layer of the epidermis, all layers of 
the follicular epithelium and the cells of the adnexal glands. Staining of lesser intensity 
was also found suprabasally. This corresponds well with the expected profile as this 
cytokeratin is known to be expressed (along with its pair CK5) in the basal cells of 
stratified epithelium and to be progressively replaced in the upper layers of epidermis 
(Nelson and Sun 1983). In the papillomas all the epithelium is CK14 positive, 
presumably reflecting a failure in normal differentiation which would tend to produce 
down regulation of this keratin pair in suprabasal epithelium in favour of the 
differentiation associated CK10 (and its pair CK1). Similarly, in the squamous 
carcinoma CK14 was also detected in all epithelial cells.
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In normal canine skin suprabasal epidermal cells, cells of the follicular infundibulum 
and those of the inner root sheath were CK10 positive. In the papillomas there was very 
little CK10 positivity with staining restricted to individual cells in the stratum spinosum 
or more widespread but very weak staining at this level. In the squamous carcinoma 
cases individual positively stained cells were detected in the keratin pearl formations 
where they were present (the most morphologically differentiated part of these tumours) 
and in a few spinous cells only. This would support the assertion that differentiation 
was not progressing in a normal manner in either papillomas or squamous carcinomas.
CK16 is a proliferation associated cytokeratin which together with its pair CK6 is found 
in proliferating stratified epithelium and in normal follicular epithelium (Eichner, Aebi 
and Sun 1986). In the normal canine skin tested CK16 was present in the hair follicles 
except in the outer root sheath and hair bulb and appeared very faintly in some 
epidermal cells. In both the papillomas and the squamous carcinomas suprabasal 
staining with this antibody was widespread in areas with spinous layer morphology.
Staining for these determinants provides a strong visual representation of the biological 
processes occurring in these tumours with regard to their cytokeratin expression. The 
expression of differentiation associated cytokeratins is very much reduced in 
comparison to normal skin whilst proliferation associated cytokeratins show greatly 
enhanced expression. The normal development of epidermis may be considered to be a 
balance between differentiation and proliferation producing orderly cell growth and it is 
apparent that the dysregulated growth which neoplasia represents is reflected in the 
cellular cytokeratin expression. Similarly, alterations in cytokeratin subclass expression
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would be expected to accompany hyperproliferation in non-neoplastic conditions 
characterised by epithelial hyperplasia such as acral lick dermatitis.
Basal cell tumour and the two most common adnexal variants, the trichoepithelioma 
and the pilomatrixoma which were also chosen for this study may be considered under 
the umbrella term of benign skin adnexal tumours. These tumours have different 
patterns of differentiation but all are cured by excision. Whilst these tumours represent 
points on a continuum of differentiation ranging from wholly undifferentiated basal cell 
tumours to growths with purely follicular or glandular morphology it has been 
traditional in histopathology to group the lesions into named categories. The purpose of 
examining them for cytokeratin subclass expression was to see whether tumour specific 
patterns could be discerned.
In all three tumour types CK14 positivity was widespread although negative 
populations of epithelial cells were detected in all growths tested except four basal cell 
tumours. This marker is widespread in all stratified epithelium and its absence in the 
negative cells suggests they may be progenitor cells, uncommitted to stratified 
differentiation.
All basal cell tumours and pilomatrixomas were uniformly negative for CK10. This 
marker was identified in a few cells in three trichoepitheliomas and may indicate a 
definable, albeit small, difference in differentiation pathway in these tumours. In the 
normal skin CK10 was detected in the follicular infimdibula and luminal root sheath 
but not in the outer root sheath so this finding suggests the cells of origin for the 
trichoepitheliomas derive from or differentiate towards the former areas and those of 
the pilomatrixoma do not.
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The proliferation-associated CK16 was found at low levels or in small numbers of cells 
in the basal cell tumours and quite strongly in foci within the trichoepitheliomas. 
Within the pilomatrixomas specific areas also tended to stain. Expression of this 
cytokeratin is likely reflect rapidly growing areas in the tumours.
The opening review of this chapter drew attention to the controversy surrounding the 
classification of cutaneous epithelial tumours where the “lumpers” favour grouping the 
lesions under broad headings and the “splitters” endeavour to subdivide and categorise 
them. What does cytokeratin subfamily immunohistochemistry add to this debate? In 
the opinion of the author this work suggests that the phenotype of each tumour is the 
important factor.
What is meant by this is that cytokeratin expression profile is intimately linked to 
cellular morphology. Thus the keratin pearls in squamous cell carcinoma, which are the 
most morphologically differentiated, are the areas which express the differentiation- 
associated cytokeratin CK10. These cells are part of the same mass as their CK10 
negative neighbours, yet they differ in protein expression. It is not novel to suggest that 
cells within a single tumour may be heterogeneous as new genetic alterations are known 
to occur during tumour progression, but the point here is that these same cells are 
morphologically, phenotypic ally, different also.
Across all the tumours tested areas of similar morphology showed similar staining 
patterns. For example, CK10 positivity where it appeared in the trichoepitheliomas was 
always seen in cells which in H&E sections were large with eosinophilic cytoplasm and 
vesicular nuclei resembling stratum spinosum.
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Considered as a whole, the heterogeneous group of adnexal tumours seem to resist 
accurate placing within very precise classifications, not least because the morphology 
can vary markedly between different fields in the same tumour, although broad 
statements can usually be made about the predominant direction of differentiation. 
Equally, it is the opinion of the author that it is not possible to demonstrate whether any 
given tumour of this type actually arose from a cell of a certain location/type (i.e. outer 
root sheath) or whether it arose from an undifferentiated cell and “chose” to 
differentiate towards a particular phenotype so systems which place great weight on the 
cell of origin may not be entirely valid.
In summary, the work presented in this chapter demonstrates that it is possible to 
visualise the location of different cytokeratin subclasses in normal canine skin and 
epithelial cutaneous tumours using immunohistochemistry. Small differences between 
the tumour classes are apparent although, as would be expected, they show evidence of 
common differentiation pathways. A logical approach where the taxonomic diligence of 
the “splitters” is combined with the practical understanding that in some cases these 
divisions are artificial and contrived would perhaps provide the most meaningful way 
forward for veterinary histopathologists.
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Chapter 4
Immunohistochemistry in tumour biology: Studies on the
p53 gene product.
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4.1.1.) Introduction to p53.
In this final chapter, moving on from the consideration of cell lineage markers as 
possible tools for the examination of tumours, immunohistochemical detection of 
accumulation of an abnormal gene product in neoplastic cells is investigated. 
Unlike the previously considered markers, detection of p53 protein offers no 
information on the derivation of a tumour but it may in time be found to aid 
accurate prognostic interpretation.
The p53 gene encodes a 53kd nuclear phosphoprotein which acts as a tumour 
suppressor. The gene product was originally discovered in the late 1970s by 
researchers working on rodents cells transformed by the SV40 virus and because 
of its association with transformation in these cells the protein was suspected to 
be a tumour antigen and the gene designated a proto-oncogene (Lane and 
Crawford 1979, Linzer and Levine 1979). Subsequently these p53 genes were 
discovered to be mutant forms (Hinds, Finlay and Levine 1989) and the normal 
(wild-type) protein product was identified and shown to be a negative regulator 
of the cell cycle and to suppress transformation (Finlay, Hinds and Levine 1989). 
p53 is involved in regulating the cell cycle but is not necessary for normal growth 
and development (Donehower et al. 1992). What this gene is pivotal in, it seems, 
is the response of the cell to “stressors”; genotoxic insults such as ionising 
radiation, and some chemicals or drugs (Kastan et al. 1991, Cox and Lane 1995).
In normal cells p53 is present at very low levels but if genetic damage occurs the 
protein accumulates and binds to target sequences of DNA and acts as a
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transcriptional activator. The accumulated p53 protein binds to specific sites in 
the promoter of a downstream effector, the cyclin-dependant kinase (CDK) 
inhibitor p21 (WAF-1, CIP-1) and upregulates expression of this gene, which by 
inhibiting the action of these enzymes, mediates cell cycle arrest at G l. Cyclin- 
dependant kinases are necessary to phosphorylate the retinoblastoma (Rb) protein 
and effect cell entry into the S phase (Steinman et al. 1994). The resulting cell 
cycle arrest provides the cell with an opportunity to repair the damaged DNA 
before cell division occurs.
In addition to initiating cell cycle arrest wild-type p53 is also capable of inducing 
apoptosis in DNA damaged cells via a separate pathway. The mechanisms 
underlying the ability of p53 to induce apoptosis are still incompletely 
understood although they are known to be distinct from the p53 activation of the 
p21 cell cycle arrest pathway as deletion of the p21 gene does not affect radiation 
induced apoptosis (Deng et al 1995, Brugarolas et al 1995). p53 and the 
apoptosis-suppressing gene bcl-2 act as effector and suppressor respectively of a 
common cell death pathway (Marin et al. 1994) and p53 has been demonstrated 
to decrease expression of bcl-2 and enhance the expression of the related bax 
gene (Miyashita et al. 1994). It appears that the active form of bcl-2 may be a bcl- 
2/bax heterodimer (Yin, Oltvai and Korsmeyer 1994) and that increased 
expression of bax favours the formation of bax/bax homodimers which 
antagonise the action of bcl-2 (Oltvai, Milliman and Korsemeyer 1993). Thus if 
the DNA is irretrievably damaged the cell is driven into p53-mediated apoptosis, 
preventing propagation of the genetic error.
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Mutations of p53 are the most common genetic alterations found in human 
cancer, appearing at high frequency in a diverse range of neoplasms (Nigro et al.
1989). The p53 gene is well conserved in evolution with regions of high 
homology being present in mammals, birds, fish and amphibians (Montenarh 
1992). The highly homologous exons 2, 4, 5, 7 and 8 code for five clusters of 
amino acid sequences known as domains I-V. Of these II-V fall into exons 5-8, 
the area of the gene which has attracted most attention (Montenarh 1992). It is 
within these highly conserved and presumably functionally critical regions of the 
gene that the vast majority (98%) of these cancer-associated mutations occur 
(Hollstein et al. 1991). These mutations translate as alterations of amino acid 
sequence which cluster in the highly conserved central region of the protein as 
illustrated in Figure 51.
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Figure 51. Frequency and distribution o f  amino acid changes in the p53 protein in 
cancer associated mutations (adapted from Levine, Momand and Finlay 1991).
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Mutations of the p53 gene may have several consequences. In most human 
cancers in which p53 mutation has been studied; colon, breast, brain and lung 
tumours, (Bartek et al. 1990, Offerhaus et al. 1992, Meling et al. 1993, Iggo et al.
1990) many of the neoplasms show a “loss” of both p53 alleles usually through 
deletion of one and point mutation of the other. This suggests that these particular 
mutations are recessive to the wild type allele and only contribute to 
tumorigenesis when wild type activity is lost.
With mutation there can be a loss of function effect as all mutants lose the ability 
to bind to the specific p53 target sites (Vogelstein and Kinzler 1992) and hence 
cannot activate effector genes meaning that the protective guard against genetic 
instability which wild type p53 provides is lost. In addition, a gain of function 
effect which can act in the heterozygous state can occur. Some, although not all, 
forms of mutant p53 can act in a dominant negative fashion by complexing with 
and inhibiting the action of wild type p53 protein (Vogelstein and Kinzler 1992, 
Gannon, Greaves, Iggo and Lane 1990). Furthermore, some p53 mutants can act 
to enhance transformation by mechanisms which do not involve complexing with 
the normal protein (Levine, Momand & Finlay 1991).
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4.1.2) Immunohistochemistry of p53: a possible role in diagnostic pathology
There is no doubt that in terms of the molecular biology of tumours p53 is a gene 
of major, possibly even central, importance. However this fact, of itself, would 
not contribute much towards the discipline of diagnostic histopathology. What 
makes p53 so interesting from a diagnostic viewpoint is that, in addition to 
abolishing functional activity, genetic mutation leads to the production of a 
stabilised mutant protein which accumulates in the cell to levels detectable by 
immunohistochemistry. In normal cells p53 levels are too low for this to be 
possible (Montenarh 1992). In certain circumstances p53 accumulation is due, 
not to genetic mutation, but to post-translational binding of the normal protein by 
cellular or viral proteins (Momand et al. 1992, Scheffiier et al. 1990, Yew and 
Berk 1992). This also represents loss of p53 biological activity.
Therefore assessment of p53 accumulation by immunohistochemistry provides a 
simple method of examining the p53 functional status of these cells. In fact, in 
cases where the functional activity of the p53 protein is altered by post- 
translational changes immunohistochemistry will demonstrate the abnormality 
where the more sophisticated technique of gene sequencing will not.
As p53 represents such a pivotal point in cell cycle control a great deal of 
research has been carried out in recent years to investigate the prognostic 
significance of p53 dysregulation in tumours. In the field of human medicine 
strong associations between p53 expression and tumour progression have been 
found in colorectal adenocarcinoma, (Baas et al 1994, Costa et al 1995) some
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types of lymphoma, (Said et al 1992, Villuendas et al 1992) breast cancer (Barnes 
et al 1993, Thor et al. 1992) and prostatic cancer (Visakorpi et al. 1992). As yet 
very little work has been published regarding p53 in the domestic species.
The aim of this study was to investigate p53 immunohistochemistry in routinely 
processed tissues from selected tumours of domestic animals using commercially 
available anti-human p53 antibodies.
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4.2.1.) Materials and Methods
In this study ninety three tumours of domestic animal origin were examined. 
These were comprised of forty equine tumours, thirty one bovine tumours and 
twenty two canine tumours. In each species relatively common malignancies 
were chosen. In the horse squamous cell carcinoma, lymphosarcoma, sarcoid and 
pituitary adenoma cases were examined, the cattle samples were from squamous 
carcinoma and lymphosarcoma cases and the dog tumours examined were 
squamous carcinomas and pulmonary carcinomas.
The equine groups were selected to provide examples of different types of 
neoplasm for comparison.
Of the sixteen equine squamous carcinomas examined, seven were ocular (three 
of these confined to the third eyelid), four were penile (one is shown in Figure 
52) and the remainder were single examples of preputial, palatine, vulval, 
perianal and gastric tumours. Squamous cell carcinoma is the most common 
equine neoplasm seen by this department (Figure 53) and can be locally 
aggressive and metastatic.
Lymphosarcoma is also quite frequently seen (Figure 54) and can sometimes be 
difficult to differentiate from non-neoplastic lymphoid infiltration. The equine 
lymphosarcoma sections in this study were from six alimentary and two splenic 
cases. Sarcoids are a special category of non-metastatic, locally aggressive 
tumours (Figure 55) and pituitary adenomas are functionally active but benign 
growths.
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Figure 52. An example o f  equine penile squamous carcinoma. The 
tumour is very large and ulcerated.
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Figure 53. Equine squamous cell carcinoma. Large eosinophilic cells form 
nests in the dermis. Some inflammatory cells are present. H&E medium power.
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Figure 54. An example o f  equine alimentary lymphosarcoma. Malignant 
lymphocytes invade the lamina propria. H&E (medium power)
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Figure 55. Equine sarcoid. The section shows interweaving bundles o f  spindle 
shaped cells. H&E (medium power)
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Of the bovine carcinoma series, seven were squamous carcinomas of the upper 
alimentary tract: one from the pharynx, three from the oesophagus and three from 
the rumen. Six were uterine carcinomas. Also included were single examples of 
squamous carcinoma of the eyelid, the larynx, the nasopharynx and facial skin. 
One tumour was widely disseminated throughout the mediastinum but the 
primary site was not identified and two were biopsy samples where the primary 
site was not known.
The canine lung tumours examined were all necropsy specimens and were 
composed of six bronchiolar-alveolar adenocarcinomas, three papillary 
adenocarcinomas and two anaplastic carcinomas. The canine squamous 
carcinomas were biopsy specimens and three were digital, two tonsillar, two 
lingual, one oral (unspecified), one perianal, one preputial and one from hindlimb 
skin.
Immunohistochemistry was carried out on formalin fixed paraffin embedded 
tissues taken from the pathology department archive. Sections of 5-7pm were cut 
onto pre-coated slides (APES: 3-aminopropyltriethoxysilane) to promote 
adhesion and dried overnight at 37°C. After de-waxing the sections were 
immersed in citrate buffer (lOmM, pH 6.0) and processed in a microwave oven at 
650W for five minutes, four times in quick succession. The container was turned 
at the breaks in processing to minimise the effects of potential hot-spots in the 
microwave oven. The slides were then allowed to cool at room temperature for 
twenty minutes. Next, a five minute incubation with 3% hydrogen peroxide in 
water to block endogenous peroxidase activity was performed. This was 
followed by ten minutes blocking, to reduce background staining, using buffered
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serum from the species in which the secondary antibody was raised. Incubation 
with the primary antibody for one hour at room temperature in a humidity 
chamber was followed by the application of a standard streptavidin-biotin 
peroxidase method (Vectastain Universal Quick Kit, Vector Laboratories, 
Burlinghame, CA, USA.) for detection. AEC (3 amino-9 ethylcarbazole) was 
used as a chromogen and the slides were counterstained with Meyer’s 
haematoxylin. With AEC aqueous mounting is required so the sections were 
coated with Supermount™ (BioGenex, San Ramon, CA, USA.) and allowed to 
dry before using DPX (BDH Laboratory Supplies, Poole, England.) to mount the 
coverslips.
Monoclonal antibodies
In the equine and bovine tissues two monoclonal mouse anti-human p53 
antibodies, DO-1 (Immunotech, Marseilles, France.) and PAb240 (Serotec, 
Oxford, England.) were used and in the canine a third, PAM801 (Pharmingen, 
San Diego, CA, USA.) was also tried. DO-1 and PAbl801 each recognise 
epitopes expressed on both wild-type and mutant p53 whilst PAb240 is specific 
for mutant protein. DO-1 and PAM801 were supplied pre-diluted and PAb240 
was used at dilutions of 1:100 and 1:50.
Tissue sections from a known p53 positive human colonic adenocarcinoma were 
used as positive controls. In the negative controls which accompanied each test 
section the primary antibody was replaced by buffered serum. In addition, normal 
equine skin sections were included.
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After immunostaining the sections were scored semi-quantitatively by counting 
the p53 positive tumour cells in each section and grouping them as follows: 
0% /-, <5%/+ , 5-25%/++ , 26-50%/+++ , >50%/++++ . Each section was scored 
by two observers (Hazel Johnston and Hal Thompson).
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4.3.1) Results
The results of the immunostaining, (Table 12.) show that extensive p53 positivity 
was present in the equine squamous carcinoma group with more limited positive 
reactions in the equine lymphosarcoma and sarcoid cases. Two bovine squamous 
carcinoma cases were also positive but no specific staining was identified in the 
the bovine lymphosarcomas, the equine pituitary tumours nor any of the canine 
tumours.
Of the equine squamous cell carcinomas fifteen out of sixteen tumours stained 
with DO-1. These tumours had specific nuclear staining and in some cases 
almost all the tumour cell nuclei were strongly positive (Figures 56 and 57). The 
same tumours stained less well with PAb240 which overall produced poorer 
staining intensity and failed to stain some tumours which were positive with the 
first antibody. The one negative result with DO-1 was from a penile squamous 
carcinoma. Out of eight equine lymphosarcomas, one alimentary tumour gave a 
positive result with both antibodies (Figure 58) and no staining was observed 
with the pituitary lesions. Of the ten equine sarcoids examined two had distinct 
staining with DO-1 which was absent with PAb240 (Figure 59). Interestingly, 
this staining had a perinuclear pattern (see discussion).
In the bovine series two carcinoma cases had positive nuclear staining with both 
antibodies. These were the eyelid lesion, in which almost all the tumour cell 
nuclei were stained, (Figure 60) and the pharyngeal squamous carcinoma in
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DO-1 PAb240 PAbl801
- + ++ +++ ++++ - + ++ +++ ++-H- -  + ++ +++ +-H-+
Equine
Squamous carcinoma 1 4 2 4 5 6 2 2 2 4
Lymphosarcoma 7 0 0 1 0 7 0 0 1 0
Sarcoid 8 0 0 2 0 10 0 0 0 0
Pituitary adenoma 6 0 0 0 0 6 0 0 0 0
Bovine
Carcinoma 18 1 0 0 1 18 1 0 0 1
Thymic lymphosarcoma 11 0 0 0 0 11 0 0 0 0
Canine
Squamous carcinoma 11 0 0 0 0 11 0 0 0 0 11 0 0 0 0
Lung carcinoma 11 0 0 0 0 11 0 0 0 0 11 0 0 0 0
Table 12. Results o f  immunohistochemical staining o f  tumour sections using 
monoclonal mouse anti-human p53 antibodies. The sections were classed by 
percentage o f  tumour cells showing positive staining such that 0 / - , <5% / + , 5-
25% / ++ , 26-50% / +++ , >50% / +-H-+ .
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Figure 56. In this particular equine squamous cell carcinoma almost all the 
tumour cell nuclei are strongly positive. DO-1 (high power)
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rigure 57. Another case ot equine squamous cell carcinoma witr 
nuclear positivity in almost all tumour cells. DO-1 (high power) 
Inset: negative control showing unstained nuclei.
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Figure 58. One equine alimentary lymphosarcoma was positive with DO-1 and 
Pab240. This sheet o f  cells was part o f  a tumour nodule. DO-1 (medium power)
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Figure 59. One o f  two equine sarcoids with positive staining. Close examination 
reveals that this staining was cytoplasmic and mostly perinuclear. DO-1 (medium  
power)
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Figure 60. Bovine squamous cell carcinoma. Most o f  the tumour 
cell nuclei are positive although the staining intensity is not as 
great as in the equine cases. DO-1 (medium power)
which a small number of tumour nuclei were positive. Again, DO-1 produced 
better staining intensity. The bovine lymphosarcomas yielded no specific staining 
and showed a high degree of background present on both test sections and 
negative controls. This finding is in agreement with the observation made in 
chapter two that bovine tissues appear prone to high background staining despite 
careful blocking treatment.
No specific p53 reactivity was detected in the canine tissues examined in this 
study even using a third antibody, PAbl801,in addition to DO-1 and PAb240.
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4.4.1.) Discussion
In this study we aimed to determine whether p53 status in selected tumours of 
domestic animals could be assessed using commercially available anti-human 
p53 antibodies. In particular we were interested in antibodies known to be 
effective for immunohistochemistry in formalin fixed tissue.
The technique proved most rewarding in the equine tumours where extensive 
expression of high levels of p53 protein were found in one particular neoplasm, 
the squamous carcinoma. The antibodies used also appeared to be successful in 
the bovine tumours, detecting p53 accumulation in two carcinoma cases. 
However, no p53 accumulation was detected in the canine tissues in this study.
Looking in detail at the equine results we see that fifteen out of the sixteen cases 
examined were positive with DO-1 and ten were positive with PAb240. In 
several of the tumours almost all of the neoplastic cells were stained. In all cases 
where staining was apparent DO-1 produced better staining intensity and the 
sections which were positive using DO-1 but failed to stain with PAb240 were 
those with a comparatively less intense stain. This suggests that the differences in 
detection are due to sensitivity or suitability of the antibodies with DO-1 being 
better for p53 detection in paraffin sections of equine (and bovine) tissues. The 
other possibility is that the discrepancies are due to detection, by DO-1, of 
stabilised wild type protein which PAb240 does not recognise. The author does 
not believe this to be the case as the differences consistently relate to intensity of
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staining where tumours with faint but recognisable staining with DO-1 have no 
discernible staining with the other antibody.
Two out of ten equine sarcoids stained positive with DO-1 but not with PAb240. 
This staining was quite intense and the difference in result between these 
antibodies does raise the possibility of detection of stabilised wild-type protein. 
However, cytoplasmic staining is rarely associated with wild type p53. As 
papillomavirus has been implicated in the aetiology of the sarcoid the possibility 
exists that this staining may represent wild-type p53, which PAb240 would not 
recognise, bound to a viral oncoprotein. However, the known p53 binding protein 
of HP Vs (Human Papilloma Virus) 16 and 18, which are involved in carcinoma 
of the uterine cervix in humans, is E6, which inactivates p53 by promoting its 
degradation, not by sequestering and stabilising it (Scheffner et al. 1990). It has 
been demonstrated that neoplasms may harbour both HPV transforming proteins 
and p53 mutations (Helland et al. 1993). Another possibility is that certain 
genetic factors are acting to interfere with the subcellular localisation of p53. For 
example, bcl-2 and c-myc acting in concert have been shown to prevent nuclear 
localisation of p53 at critical points in the cell cycle (Ryan et al. 1994).
The results of the bovine series corresponded with the finding in the horse that 
DO-1 produced better staining, but neither positive bovine tumour produced as 
intense a stain as shown by most of the equine tumours.
The complete negativity of the canine results was perhaps surprising as our 
sample selection was weighted to enhance the likelihood of p53 overexpression 
in the test group. Thus pulmonary carcinomas were examined because mutations
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of p53 are recognised in human lung cancer patients (Fontanini et al. 1994, Iggo 
et al. 1990). Dogs are allowed to live a full lifespan and are exposed to the same 
environmental conditions as their human owners which makes them interesting 
models for comparison with man. However, none of the canine tumours in this 
study showed specific reactivity with any of the antibodies used, therefore either 
these antibodies do not recognise canine p53 or no p53 accumulation exists in 
any of these tumours. The use of several antibodies which recognise different 
epitopes should increase the chance of detection but it remains possible that 
none of these are appropriate for use in the dog. It has been suggested that the 
overall incidence of p53 mutation is lower in the dog than in man and in one 
study where the highly conserved exon eight of the p53 gene was sequenced only 
one tumour out of fifteen was found to have a mutation (Mayr et al. 1994). It may 
be that these particular neoplasms in the dog do not involve p53 mutations whilst 
others do. Sagartz et al. (1996) used a polyclonal anti-p53 antibody (CM-1, 
Signet Laboratories, Dedham, MA) to investigate osteogenic tumours in dogs and 
found that the p53 protein was overexpressed in the majority of osteosarcomas 
tested. This finding appeared to correlate with aggressive biological behaviour in 
the tumours. In a recent study Wolf et al. (1997) used the same antibody to 
examine canine colorectal tumours. Their findings were contrary to data derived 
from studies on similar studies on humans as benign lesions were found to stain 
with greater frequency than malignant lesions. The authors suggest this may 
represent an early role for p53 alterations in these tumours and conclude that p53 
is not a prognostically useful marker in this situation.
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Variability in technique is a major problem in assessing the significance of 
immunohistochemical results. Different methods of fixation and retrieval, 
different concentrations and sensitivities of antibodies, incubation times and 
conditions and detection systems all influence results. In addition, the 
quantification of results is subjective.
In this study the antibodies were selected for their ability to react with formalin 
fixed paraffin embedded tissue to allow examination of archival materials. The 
range of antibodies available is ever increasing but the numbers applicable to 
formalin fixed tissue are still comparatively small. The manufacturers had no 
data regarding the use of these antibodies in the species examined here. By 
testing on human control tissue microwave processing was found to be necessary 
to unmask the relevant epitopes, even in the case of PAb240 where the data sheet 
stated this was not the case. This type of pre-treatment is associated with 
problems of the tissues floating off the slides, becoming overheated and showing 
increased background staining. In these experiments occasional sections proved 
very difficult to process due to floating but careful turning of the container during 
processing helped to minimise section overheating. Non-specific background 
staining occurred in some of the canine tissues and bovine lymphosarcomas but 
was not a significant problem. There is a concern that microwave processing and 
other pre-treatment could generate spurious positive results but if suitable control 
sections are used we do not believe this to be a problem, at least in terms of p53 
which due to its short half life of less than twenty minutes (Reich, Oren and 
Levine 1983) has a normal cellular concentration below the threshold of 
detection for immunohistochemistry (Montenarh 1992). We found no specific
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reactivity in normal tissue nor in the negative control sections and non-neoplastic 
cells in positive tumour sections were unstained. This strongly suggests that the 
processing itself does not cause staining.
Largely, immunohistochemical detection of p53 is a marker of genetic mutation 
but there are exceptions to this. Immunohistochemically negative cases can occur 
in the presence of a mutated gene if the mutation is a stop signal or a gross 
deletion where no p53 protein is produced at all. This situation is rare but is 
recognised in a small proportion of human malignancies (Wynford-Thomas 
1992). Similarly, some mutations may not stabilise the protein sufficiently for 
immunohistochemical detection and it is not clear at present what degree of 
functional impairment these mutations cause, as partial stabilisation could mean 
only partial inactivation. Conversely, stabilised protein can be detectable in the 
absence of genetic mutation due to binding of the normal p53 protein by the 
transforming proteins of oncogenic DNA viruses such as Elb of adenovirus type 
5 (Yew and Berk 1992) or cellular gene products like mdm2 (Momand et al 1992, 
Wu et al. 1993) which has a regulatory effect on p53 and itself can be a target for 
mutation in some neoplasms.
With the caveats mentioned above, immunohistochemistry is a simple and 
effective way of examining p53 functional status in cells and in fact can be more 
informative than the more laborious and expensive process of DNA sequencing. 
This study suggests that p53 assessment in domestic animal tumours may in the 
future prove an adjunct to traditional methods of microscopic tumour diagnosis 
and prognostication.
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